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Abstract
This thesis makes an original contribution to the area of fast protein analytics mainly for appli-
cation in combination with high throughput process development. A central topic is the more
efficient utilization of equipment routinely used for protein analysis and quantification. This was
shown to be possible both with purely practical measures as well as by applying multivariate
analysis and calibration in areas where traditionally only univariate data is used. With re-
gard to multivariate analysis, it was shown that in combination with spectroscopy, multivariate
calibration can exploit the unique characteristics of protein absorption spectra. This enables
selective quantification of protein concentrations in protein mixtures which is both label-free
and non-invasive. Further, multivariate calibration is used in order to evaluate analytical chro-
matograms of which the resolution of the components to be quantified was not sufficient to
obtain precise results otherwise.
The first part of this thesis is concerned with the development of generic approaches to
increase the throughput of protein analysis based on size exclusion chromatography (SEC). By
interlacing the sample injections, the lag time before elution of the first sample components
can be eliminated. This lag time equals the interstitial volume of the applied SEC column.
Importantly, it was possible also to eliminate the lag time post elution of the molecules to be
analyzed. This was done by operating two columns in parallel on the same HPLC system.
For this configuration, only one additional pump and two valves are necessary. The interlaced
injections were performed on both columns at the same time, whereat the samples were injected
alternating on the two columns. The exact timing of each injection was adjusted to allow
only eluate containing samples components which was to be quantified to pass through the UV
detector. The controlling of the chromatography system devices required a special programming
to enable correct assignment of a recorded chromatogram to the respective injected sample. The
developed approach to increase throughput of SEC was shown to be robust and to deliver results
which were identical to SEC performed in conventional mode. A conducted case study showed
that for aggregate quantification of a monoclonal antibody, it was possible to obtain a threefold
reduction in analysis time. This approach can be applied for any analysis based on SEC. The
part of the lag time which can be eliminated will depend on the duration of each lag phase and
on the ratio of the overall lag time to the duration of the information phase.
The second approach to increase throughput in SEC was based on dynamic multivariate
calibration of the quantitative relationship between a chromatogram and analyte concentra-
tions. The idea was to use multivariate calibration to compensate for low chromatographic
resolution in the strive for fast analysis. As an example of use, the quantification of protein-
polymer conjugates was chosen. In this particular case, native protein along with mono-, di-,
and tri-conjugated protein were present in the samples to be analyzed, all of which were to be
quantified. Initially, the choice of a short SEC column in combination with a high flow rate
enabled a sufficiently short analysis time. The tradeoff for fast analysis was a very low chro-
matographic resolution of the di- and tri-conjugated proteins. To achieve precise quantification
despite this low resolution, multivariate calibration was used to establish a quantitative correla-
tion between chromatogram and analyte concentrations. The precision of different multivariate
regression methods were compared quantitatively and multilinear regression was shown to re-
sult in the highest precision. Importantly, a dynamic approach was included in the multivariate
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calibration in order to cope with changes in column performance over time which are often
inevitable. This measure contributed significantly to the precision of the analysis. In conclu-
sion, it could be shown that multivariate calibration can compensate for low resolution. Hence,
multivariate calibration can contribute to the achievement of protein quantification based on
analytical chromatography which is fast enough to fit the concept of high throughput process
development. In this case, dynamic multivariate calibration was used in combination with inter-
laced sample injections and together these measures resulted in an analysis time of two minutes.
A significant part of this thesis consists of an original contribution to the application of
protein absorption spectra for selective protein quantification. It was investigated whether the
information contained in the unique absorption spectra of proteins can be used for selective
quantification in protein mixtures. The accomplished work show that multivariate calibration
can indeed be used to establish a precise correlation between absorption spectra and selective
protein concentrations. With respective calibrations, it was possible to perform selective pro-
tein quantification in the range 0.07 - 1.5 g/L and for up to four different proteins. Mid-UV
protein absorption spectra are known to be insensitive to moderate changes of the solvent (e.g.
ion strength or pH). Validation experiments confirmed the robustness of the spectra against
solvent changes in a range relevant for liquid chromatography. The applicability of this new
method was illustrated by a resin screening in packed column high throughput format. Because
selective protein quantification based on absorption spectra was applied instead of analytical
chromatography for analysis of the samples, both the time needed for analysis and the workload
for the experimenter was decreased significantly. Importantly, the achieved increase in analyt-
ical throughput was achieved without compromising the quality of the results when compared
to results obtained by analytical chromatography. A very important aspect of the developed
method for selective protein quantification, is the degree of spectral similarity in combination
with the accuracy and precision of the device used to record the spectral data. Hence, further
work was dedicated to uncover both possibilities and limitations of selective protein quantifi-
cation based on protein absorption spectra. Principal component analysis was performed on
a broad range of protein absorption spectra to investigate their common characteristics and
differences. The principal component analysis was used both for cluster analysis and to define a
measure for spectral similarity. For binary protein combinations, the calibration precision was
shown to decrease exponentially with the defined spectral similarity factor. This correlation
will depend on the applied spectrophotometer and it can be used to determine a priori whether
a calibration for certain proteins will be successful or not. To enable fast measurement of many
samples, most often single beam plate reader devices are used. It was shown that a plate reader
device is not precise enough to enable selective quantification of two monoclonal antibodies of
which the spectra differed only by 0.6 %. However, when applying a double beam photometer
where the measurements are performed in cuvettes, this calibration was successfull.
In the final part of this thesis, preliminary studies of an in-line application of spectral based
selective protein quantification for process control is presented. The previously presented work
proved that mid-UV protein absorption spectra are very useful for selective protein quantifi-
cation. The objective here was to show that this approach can also function in a real time
application during the performance of preparative chromatography. Such an application re-
quires the use of a diode array detector in order to acquire full spectra on a real time basis. The
resolution of a diode array detector is in general lower compared to monochromator based equip-
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ment used in the previous work. However, the application of spectral based selective protein
quantification proved to result in very precise signals even for proteins with very similar absorp-
tion spectra. Hence, it was concluded that selective protein quantification based on mid-UV
absorption spectra are indeed qualified for applications related to process control purposes.
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Zusammenfassung
In der vorliegenden Doktorarbeit werden neuartige Methoden zur Proteinanalytik fu¨r die nwen-
dung in Kombination mit Hochdurchsatz-Prozessentwicklung pra¨sentiert. Ein zentrales Thema
ist die effizientere Nutzung von Gera¨ten, die routinema¨ßig zur Proteinanalytik eingesetzt wer-
den. Es wurde gezeigt, dass die Effizienz gesteigert werden konnte, indem alternative Wege zur
Durchfu¨hrung der Analysen entwickelt wurden. Weiter konnte gezeigt werden, dass der Einsatz
von multivariaten Methoden zur Datenanalyse und Datenauswertung die Qualita¨t der angewen-
deten Analysen erhalten konnte bei gleichzeitiger Reduzierung der zur Analyse beno¨tigten Zeit.
In Verbindung mit Spektroskopie wurden multivariate Methoden benutzt, um die einzigartigen
spektralen Charakteristika von Proteinen zu verwerten. Somit wurde selektive Proteinquan-
tifizierung u¨ber Absorptionsmessungen in Proteinmischungen ermo¨glicht. Weiter wurde multi-
variate Kalibrierung bei der Auswertung von analytischen Chromatogrammen eingesetzt, bei
denen die Auflo¨sung zwischen den Komponenten zu gering war, um eine genaue Quantifizierung
u¨ber Peakfla¨chen zu gewa¨hrleisten.
Der erste Teil dieser Dissertation befasst sich mit der Entwicklung eines generischen Vorge-
hens zur Erho¨hung des Durchsatzes von Analysen basierend auf Gro¨ßenausschlusschromatogra-
phie (SEC). Es konnte gezeigt werden, dass eine Verschachtelung der Probeninjektion die
Verzo¨gerungszeit vor der Elution der Probenkomponenten einsparen konnte. Diese Verzo¨gerungs-
zeit ist gleich dem interstitiellen Volumen der jeweils genutzten Chromatographiesa¨ule. Zudem
war es mo¨glich, auch die Verzo¨gerungszeit nach der Elution der letzten zu quantifizierenden
Probenmoleku¨le nahezu vollsta¨ndig zu eliminieren, indem zwei Sa¨ulen gleichzeitig an einer
Chromatographieanlage betrieben wurden. Hierzu wurden lediglich eine zusa¨tzliche Pumpe
und zwei Ventile beno¨tigt. Anschließend, wurde die Verschachtelung der Injektionen auf bei-
den Sa¨ulen gleichzeitig durchgefu¨hrt, wobei die Proben alternierend auf beiden Sa¨ulen injiziert
wurden. Die genauen Zeitpunkte der einzelnen Injektionen wurden so auf einander abgestimmt,
dass anna¨hernd ausschließlich die Informationsphase im Detektor erfasst wurde. Die Steuerung
der Gera¨teeinheiten erforderte eine besondere Programmierung, um einer detektierten Infor-
mationsphase die jeweils injizierte Probe zuzuordnen. Die entwickelte Methode erwies sich als
sehr robust und wies die gleiche Pra¨zision und Richtigkeit der urspru¨nglichen Analysemethode.
Auf diese Weise konnte der Probendurchsatz an einer einzelnen Chromatographieanlage fu¨r die
Bestimmung der Aggregatanteilen von Antiko¨rperlo¨sungen verdreifacht werden. Die entwickelte
Methodik kann fu¨r jede Analyse, die auf Gro¨ßenausschlusschromatographie basiert, angewendet
werden. Die anteilige Verzo¨gerungszeit, die eingespart werden kann, ha¨ngt von der Verteilung
vor und nach der Informationsphase, sowie dem Verha¨ltnis von Verzo¨gerungszeit zur Dauer
der Informationsphase ab. Des Weiteren wurde multivariate Kalibrierung in dynamischer Form
fu¨r die Auswertung von chromatographischen Daten entwickelt und eingesetzt. Das Ziel war
es, mittels multivariater Kalibrierung trotz unvollsta¨ndiger Trennung von Probenmoleku¨len bei
SEC-Analysen richtige und pra¨zise Analyseergebnisse in quantitativer Form erzielen zu ko¨nnen,
und somit eine schnellere Analytik zu ermo¨glichen. Als Anwendungsbeispiel wurde die Anal-
yse von Protein-Polymer Konjugaten mittels SEC gewa¨hlt. Es sollte sowohl natives Protein
als auch mono-konjugiertes, di-konjugiertes und tri-konjugiertes Protein quantifiziert werden.
Durch Benutzung einer kurzen Sa¨ule bei hoher Flussrate verku¨rzten sich die Analysezeiten deut-
lich, doch fu¨hrte dies gleichzeitig zu einer Verminderung der chromatographischen Auflo¨sung.
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Um die erniedrigte Auflo¨sung zu kompensieren, wurde multivariate Kalibrierung benutzt, um
einen quantitativen Zusammenhang zwischen den Chromatogrammen bekannter Proben und die
in den Proben beinhalteten Analytkonzentrationen herzustellen. Die Genauigkeit verschiedener
multivariater Kalibrierungsmethoden wurde quantitativ miteinander verglichen. Mittels multi-
linearer Regression wurden die ho¨chsten Genauigkeiten fu¨r die Kalibrierungen erreicht. Des
Weiteren wurde ein dynamischer Kalibrierungsansatz entwickelt, um eine A¨nderung in der
Auftrennungsleistung der Sa¨ule u¨ber die Zeit korrigieren zu ko¨nnen. Dadurch konnte die
Genauigkeit der Methode signifikant gesteigert werden. Die Arbeit zeigte, dass die Anwendung
von multivariater Kalibrierung eine niedrige Peak-Auflo¨sung kompensieren kann. Schließlich
konnte durch die Kombination aus multivariater Kalibrierung und verschachtelter Probeninjek-
tionen eine genaue und pra¨zise Analytik fu¨r Protein-Polymer-Konjugate mit einer Analysezeit
von nur 2 Minuten erreicht werden.
Der Hauptteil dieser Arbeit liefert einen neuen technologischen Beitrag in der Nutzung von
Proteinabsorptionsmessungen zur selektiven Proteinquantifizierung. In diesem Teil der Arbeit
wurde untersucht, ob die Information der charakteristischen Absorptionsspektren von Proteinen
auch zur selektiven Quantifizierung genutzt werden kann. Die durchgefu¨hrten Entwicklungs-
und Validierungsarbeiten auf diesem Gebiet zeigten, dass multivariate Kalibrierung eingesetzt
werden kann, um eine Korrelation zwischen Absorptionsspektren und Proteinkonzentrationen
in einem Gemisch zu bestimmen. Mit jeweiligen Kalibrierungen war es mo¨glich, selektiv Pro-
teinkonzentrationen im Bereich von 0.07 g/L - 1.5 g/L von bis zu 4 Proteinen zu quantifizieren.
Validierungsversuche besta¨tigten die Robustheit der entwickelten Quantifizierungsmethode ge-
genu¨ber A¨nderungen der Lo¨sungs-mitteleigenschaften in einem Bereich, der relevant fu¨r pra¨pa-
rative Chromatographie ist. Die Anwendbarkeit dieser Methode wurde in Screenings von Ad-
sorbermaterialien im Hochdurchsatzformat gezeigt. Im Vergleich zu einer Analyse mittels ana-
lytischer Chromatographie konnten sowohl die Analysezeit als auch der Arbeitsaufwand deutlich
verringert werden. Es ist hervorzuheben, dass die Steigerung des Durchsatzes erzielt werden
konnte, ohne die Qualita¨t der Ergebnisse zu beeinflussen.
Sehr wichtige Einflussparameter der entwickelten analytischen Methode sind das Maß der
Unterschiedlichkeit in den Proteinabsorptionsspektren und die Genauigkeit des Messinstru-
mentes, mit der die Spektren aufgenommen werden. Daher wurden in einem weiteren Ab-
schnitt dieser Arbeit Untersuchungen durchgefu¨hrt, die sowohl die Genauigkeit und Robus-
theit der Analysemethode, als auch ihre Limitierungen aufzeigen sollte. Die Methode der
Hauptkomponentenanalyse wurde eingesetzt, um A¨hnlichkeiten und Unterschiede in den Ab-
sorptionspektren zu untersuchen. Zuna¨chst wurde eine Clusteranalyse durchgefu¨hrt. Zudem
wurde die Hauptkomponentenanalyse angewendet, um einen Faktor fu¨r spektrale A¨hnlichkeit zu
definieren. Fu¨r bina¨re Proteingemische zeigte sich eine exponentielle Abnahme der Genauigkeit
mit zunehmender A¨hnlichkeit der Spektren. Vorherige Kenntnis u¨ber diesen Zusammenhang
kann dazu verwendet werden, um a priori vorhersagen zu ko¨nnen, ob die Analysemethode
sich mit ausreichender Genauigkeit etablieren la¨sst. Um mo¨glichst schnell Proben zu messen,
werden oft Einstrahl-Photometer fu¨r Mikrotiterplatten verwendet. Es zeigte sich jedoch, dass
ein solches Photometer nicht die Genauigkeit bietet, um zwei monoklonale Antiko¨rper, deren
Spektren sich nur um 0,6 % unterscheiden, selektiv zu quantifizieren. Bei Verwendung eines
Doppeltstrahlphotometers und Messung in Ku¨vetten war selektive Quantifizierung allerdings
mit hoher Genauigkeit mo¨glich.
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Im letzten Teil der Arbeit wurde eine Machbarkeitsstudie zur einen Echtzeit-Anwendung
der Spektralanalytik durchgefu¨hrt. Die Mo¨glichkeit selektive Proteinquantifizierung in Echtzeit
durchzufu¨hren, ko¨nnte zur Prozesskontrolle bei chromatographischen Trennungen von Proteinen
im pra¨parativen Maßstab eingesetzt werden. Diese Anwendung beno¨tigt ein Spektrophotome-
ter mit einem Diodenarraydetektor, um ganze Spektren in Echtzeit aufnehmen zu ko¨nnen. Die
Auflo¨sung eines Diodenarraydetektors ist im Vergleich zu den in den vorigen Arbeiten benutzen
Monochromatorbasierten Gera¨ten niedriger. Dennoch konnte gezeigt werden, dass die Auflo¨sung
ausreichend war, um pra¨zise selektive Proteinsignale u¨ber den Elutionsbereich zu generieren. Es
wird daher als vielversprechend angenommen die Methode auch zur Prozesskontrolle einzuset-
zen.
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1 Introduction
1.1 Preface - From Quack to Exhaustive Regulation
The business of manufacturing and selling substances with the purpose to bring healing or re-
lief to individuals suffering from illness has undergone vast changes. Until the end of the 19th
century, most drugs were prepared in pharmacies and there was no regulation or restriction of
claimed efficacy or safety of the drugs. Around this time pharmacies began to develop from
small manufacturers into pharmaceutical companies and a new industry was born. Insulin and
antibiotics were the first bio-pharmaceutical blockbusters and many of today’s large pharma-
ceutical companies originated around this business. Soon came the first major scandals and as a
reaction to each scandal came new laws and regulations. The early legislation mostly aimed to
secure a correlation between label claim and actual content. Since then, continuous addition of
laws and guidelines have made the pharmaceutical industry subject to very detailed regulation,
both with regard to development, testing, production and admission/licensing. Manufacturing
is required to be at state of the art and numerous guidelines from different agencies and or-
ganizations have been issued describing what the current state of the art is. State of the art
protein purification processes are required to be based on identified product quality attributes
and their detailed and documented linkage to process parameters. At the stage of manufac-
turing a detailed process control strategy must be in place. The developed control strategy is
aimed at ensuring very high as well as highly reproducible quality based on different control
elements and the knowledge of the links between process parameters and product quality. A
control strategy consists of numerous elements including process control elements such as Proce-
dural Controls and Process Parameter Controls and testing control elements such as In-Process
Testing, Specifications, and Process Monitoring.
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1.2 Therapeutic Proteins
Therapeutic proteins can be divided into three groups: therapeutic proteins with enzymatic
or regulatory activity (for replacement therapy e.g. growth hormone, insulin, blood factors),
therapeutic proteins with special target activity (e.g. monoclonals antibodies), protein vaccines
(against pathogens or treatment of cancer and autoimmune diseases). Together they have an
enormous marked value and today it is impossible to imagine a pharmaceutical market without
therapeutic proteins.
Compared to small molecules therapeutics, protein therapeutics are challenging to manu-
facture and due to their size and complexity also elaborate to analyze and characterize. Due
to the biologic origin and the complexity of the therapeutic proteins, a final drug product ad-
ministered to a patient will never consist only of numerous identical protein molecules in an
appropriate matrix. Much rather it is a well defined population of protein species: Some related
to the main product such as charge variants, aggregates, and glycoforms and some which are
a reminiscence of the biological host in form of host cell proteins. Purification of therapeutic
proteins from their biological source must be performed under gentle conditions in order to
preserve the biological function and mostly rely on a set of unit operations including but not
limited to filtration, chromatography, centrifugation, precipitation, and crystallization.
The introduction of high throughput techniques has modernized the field of protein purifi-
cation process development over the past decade. While high throughput techniques such as
automation, parallelization, and scale miniaturization has long been applied for screenings in
the field of bioprocess development, this was not the case for purification process development
at the turn of the millennium. The main driving force in this progress is the need for very
short purification process development times and the requirement for a deeper knowledge and
understanding of the processes.
1.3 The Dawn of Modern Protein Purification Process Development
As it has been for decades, liquid chromatography is still the central unit operation for biomolecule
purification. When developing a purification process step based on liquid chromatography, there
is a vast number of solid and liquid phases to choose from and the total number of possible
parameters influencing any given separation process exceeds by far what can be tested in a
sequential packed column mode. Hence, it is not a surprise that the first reported application
of high throughput techniques for protein purification process development was related to chro-
matography. This first report described a parallel micro scale experimentation in micro titer
plate format with automated liquid handling and was published by Thiemann et al. in 2004.
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1.3 The Dawn of Modern Protein Purification Process Development
++ +
conventional process development modern process development
The authors suggested that due to high number of experiments necessary for a systematic varia-
tion of the relevant parameters in the optimization of chromatographic process step, automation
of the liquid handling would bring substantial benefit with regard to experimental throughput.
Where this initial work published by Thiemann et al. was aimed at the optimization of single
purification step, Rege et al. in 2006 proposed a micro plate based screening method to identify
the best sequence of chromatography steps and hence named their approach high throughput
process development. Hereby they had named a new field within in protein purification research
and became the herald of a new era in protein purification process development.
1.3.1 Literature Summary
A literature search on the subject of high throughput process development1, of which the quan-
titative result is displayed in Fig. 1, reveals the novelty of this field. Up to 2007 there were only
a few publications dealing explicitly with the theme of high throughput process development.
However, in 2010 the interest in the subject had grown to an extend which enabled the first in-
stallment of a conference series dedicated to the theme. The increasing interest is also reflected
in the number of publications which increased significantly after the year 2010. The literature
search was limited to unit operations mainly used for protein purification and hence does not
include work on protein refolding or crystallization. In summary, the applications found were
liquid chromatography in batch and column mode, precipitation, and extraction in aqueous two
phase systems.
Many of the early publications in the field were mainly concerned with the development
of tools and approaches for efficient screening procedures (e.g., Thiemann et al., 2004; Rege
et al., 2006; Wiendahl et al., 2008). In the publication by Rege et al. (2006), concern was
expressed towards the equivalent distribution of the relative small amounts of chromatographic
resin used in the conducted experiments. This concern was addressed and a solution proposed
the same year by Herrmann et al. who presented a device which could produce equally sized
resin plaques in a 96 well format. Most recently, an in-process photometric resin quantification
has been presented in order to correct for pipetting error in resin distribution (Kittelmann et al.,
2012; Li et al., 2012).
Up to now, successful applications of high throughput process development was mainly
demonstrated with monoclonal antibodies (Wierling et al., 2007; Bergander et al., 2008; Coff-
man et al., 2008; Kelley et al., 2008a,b; Kramarczyk et al., 2008; Wensel et al., 2008; Rodrigo
1Search conducted in the on-line collection of scientific publications ScienceDirect and academic search service
Web of Knowledge. In both data bases, two searches were conducted. One the therm ‘high throughput process
development’ and one on ‘high throughput’ together with ’protein purification’.
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Figure 1: Number of pub-
lications on high throughput
process development for pro-
tein purification. The search
was conducted both with the
specific term ‘high throughput
process development’ (Legend:
HTPD) and with a combination
of ‘high throughput’ and ‘protein
purification’ (Legend: HT). Publi-
cation which came up under both
searches are included only in the
numbers for HTPD publications.
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and Nilsson-Va¨limaa, 2010; Toueille et al., 2011; Oelmeier et al., 2011; Morrison et al., 2011;
Gronberg et al., 2011; Treier et al., 2012b; Oelmeier et al., 2012; Konstantinidis et al., 2012b).
This is thought to be both a reflection of the vast number of monoclonal antibodies in the
biopharmaceutical pipelines as well as the fact that these molecules are subject to platform
processing. Platform processes offers a unique opportunity to use high throughput tools e.g.
for the assessment of platform fit of new molecules (McDonald et al., 2010). A high number of
reports was based on work with model proteins in order to bring proof of concept to new ap-
proaches within high throughput process development (e.g., Bensch et al., 2007; Susanto et al.,
2008; Kumar et al., 2009; Susanto et al., 2009; Treier et al., 2012c,a; Osberghaus et al., 2012b,a;
Li et al., 2012). Many of the reports which applied model proteins came from academia and
demonstrated approaches to elevate high throughput process development beyond mere screen-
ings. In 2008 Susanto et al. showed how model parameter for mechanistic modeling of large
scale chromatography can be determined from high throughput data. Besides mechanistic mod-
eling, also different kinds of search algorithms were reported for use in combination with high
throughput experimentation. In 2009 Susanto et al. reported successful application of a ge-
netic search algorithm for process optimization and most recently the application of a hybrid
simplex algorithm was reported (Konstantinidis et al., 2012a). Besides search algorithms and
mechanistic modeling, the literature also includes applications of statistical approaches such as
quantitative structure-efficacy relationship modeling (Mazza et al., 2002), ANOVA modeling
(Wensel et al., 2008), and design of experiments (e.g., Toueille et al., 2011; Oelmeier et al.,
2011; Treier et al., 2012c; Fogle and Persson, 2012).
1.3.2 Analytics Applied in High Throughput Process Development
With very limited exceptions, the complete work published on high throughput process devel-
opment uses univariate spectroscopic measurements, either as a preliminary analytics or exclu-
sively. The exclusive use of univariate spectroscopic measurements is only sufficient for complete
evaluation of the performed experiments when very pure protein is applied. This approach can
be used to determine e.g. binding capacity. However, if more proteins are involved other an-
alytical methods are necessary. Besides spectroscopic measurements, high-performance liquid
16
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chromatography (HPLC) is very often applied as analytical mode of choice when performing
high throughput process development. Often, the reported assays are based on size exclusion
chromatography (Sunasara et al., 2003; Coffman et al., 2008; Kramarczyk et al., 2008; Rodrigo
and Nilsson-Va¨limaa, 2010; Ma et al., 2010; Toueille et al., 2011; Morrison et al., 2011; Treier
et al., 2012b). Also hydrophilic interaction chromatography (Sunasara et al., 2003), ion ex-
change chromatography (Coffman et al., 2008), and reversed phase chromatography (Mazza
et al., 2002; Thiemann et al., 2004) have been reported. Besides HPLC, gel electrophoresis and
enzyme-linked immunosorbent assay (ELISA) are the most applied techniques for selective or
specific protein analysis and quantification within high throughput process development. Gel
electrophoresis was most often reported as analytical method of choice in work that dealt with
proteins other than monoclonal antibodies: angiotensin-II-generation enzyme (Thiemann et al.,
2004), α-amylase and scFv-β-lactamase (Rege et al., 2006), penicillin G acylase (Zhou et al.,
2008), and NN2 (Sanaie et al., 2012). ELISA was reported for quantification of host cell pro-
teins. The use of mass spectrometry was found in only one application where it was used to
quantify host cell proteins (Wierling et al., 2007)
1.4 Analytical Bottleneck
In 2005, Bensch et al. published the first review related to high throughput process development.
In this review and in a publication that followed in 2006 by Rege et al., one of the key problems
of this new technology which they touched upon, but gave no solution to, was the lack of
analytical throughput. Bensch et al. described the problem as an analytical bottleneck which
creates a situation with an inherent trade off between analytical information and analysis time.
To be able to gain full advantage of the high experimental speed which has been enabled
in protein purification process development, the trade off between analytical information and
analytical speed must be minimized. Hence, it is necessary to develop robust analytical methods
which can match the experimental throughput which is possible today to bring relief to this
analytical bottleneck. As size exclusion chromatography and spectroscopic measurements were
found to be the most frequently applied analytical methods within high throughput process
development, a more detailed description of the possibilities and draw backs of these methods
is presented.
1.4.1 Size Exclusion chromatography
Analysis based on size exclusion chromatography is very straight forward to establish. However,
this advantage is combined with a very limited number of measures which can be applied to
enable faster analysis. Analysis based on size exclusion chromatography is often time consuming.
This is reflected in the reported analysis times which range from 10 min to 40 min per sample
(e.g., Thiemann et al., 2004; Coffman et al., 2008). Further, the method can only be parallelized
by numbering up the available of HPLC systems.
In general, different measures can be taken in order to enhance the speed of analysis based
on chromatography. Steeper gradients, higher flow rates or shorter columns can be applied,
however, these measures will all influence resolution in a negative direction and hence decrease
2The authors inform that it is a small protein consisting of a highly glycosylated 104-amino acid polypeptide
expressed in Chinese hamster ovary cells
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Figure 2: The correla-
tion of analysis time and
achieved chromatographic
resolution for two differ-
ent column lengths. The
results are based on the
separation of the monomer
and dimer form af a mon-
oclonal antibody using size
exclusion chromatography.
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the quality of the obtained analytical information. The van Deemter equation decsribes the re-
solving power of a chromatographic column as a function of various flow and kinetic parameters.
According to the classical Van Deemter equation3,
H = A+
B
u
+ Cu
the increase in linear flow rate (u) is directly proportional to an increase in the plate height (H).
However in reality the situation is more favorable, in the sense that a two fold increase in linear
flow rate will not lead to a two fold increase in plate height. Hence, there is some advantage
with respect to analysis time in increasing column length and linear flow rate at the same time
(Popovici and Schoenmakers, 2005).
Fig. 2 shows the timely advantage which can be gained by increasing the column length. It
can bee seen that with decreasing analysis time (increasing flow rate) the advantage with respect
to analysis time decreases. Further, this approach has a limitation in the stability of the resin
particles, which is markedly low in the case of size exclusion chromatography. This is due to the
fact that resin particles used for size exclusion chromatography must have a very high porosity.
As the resistance to mass transfer (C) also has an impact on plate height, the particle diameter
3H = plate height, A = Eddy-diffusion, B = diffusion coefficient, C = reisitance to mass transfer, u = linear
flow velocity
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is important with respect to resolution as it influences the mass transfer. By decreasing the
particle size, the plate height is increased and therefore separation efficiency will increase (see
Fig 3). If the wish is to increase analysis time, the flow rate can then be increased and resolution
maintained when compared to the achievable resolution with larger particles. The limitation
to this approach is again the mechanical stability of the resin particles as the back pressure
created in the column will increase with decreasing particle size. Hence, all together there is
need for alternative ways to increase the throughput of protein analysis based on size exclusion
chromatography.
1.4.2 Protein Spectroscopy and Intrinsic Protein mid-UV Absorption
In general, spectroscopic methods for quantitative and qualitative protein analysis are widely
applied. Spectroscopic methods are commonly used to asses protein secondary and tertiary
structure. Numerous techniques are available such as nuclear magnetic resonance (NMR), X-
ray, UV absorption and fluorescence, circular dichroismus (CD), light scatter measurements,
and FT-IR spectroscopy. NMR and X-ray are often applied for determination of protein struc-
ture. These techniques require very sophisticated instrumentation and are not used for routine
measurements. CD spectra are related both to primary sequence and the secondary structure
of a protein or peptide. Primarily, CD measurements are used for investigation of changes in
conformation e.g. unfolding and refolding and metal-protein interactions. Further, CD is often
used to investigate the interaction of chiral drugs with proteins (Bertucci et al., 2010). Of all
the spectroscopic methods mentioned, absorption and fluorescence are the most simple both in
terms of equipment and interpretation of the results.
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Figure 5: top: UV absorption
spectra of 27 proteins. bottom:
Three UV spectra representative of
the extremes with in the 27 measured
spectra. Proteins containing heme
groups were omitted here as they
are out of scope in the following work.
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The comprehensive advancement of high throughput screening within biological and bio-
chemical research and development has necessitated miniaturized and parallelized methods for
protein concentration determination. Hence, many colorimetric and fluorometric protein quan-
tification methods are today adapted to micro plate formats (Stoscheck, 1990; Lorenzen and
Kennedy, 1993). Also protein quantification via intrinsic absorption is very well established and
widely applied in micro plate formats. Most of the reported applications deal with very pure
protein as total protein quantification is then a very straight forward procedure. For absolute
protein quantification in protein mixtures via intrinsic absorption, the use of the absorption at
205 nm has been proposed (Kreusch et al., 2003). There has been reported some use of intrinsic
absorption spectra measured in plate format for investigation of protein stability (Dasnoy et al.,
2011). However, when it comes to selective quantification in mixtures, the general opinion seems
to be that absorption and fluorescence measurements in the UV-range lack selectivity, as only
the sum signal of the contributing amino acids can be measured (Staub et al., 2011). If a high
degree of the spectral data recorded form a protein mixture is caused by the intrinsic absorbance
of the proteins, it should be possible to correlate the spectral data to protein concentrations.
The robustness of such an approach will depend on the extend of other factors influencing the
spectra and to what levels these can be controlled. Further, it will depend on how pronounced
the spectral differences are compared to general measurement noise and external influences.
The delocalized electrons of both peptide bonds and aromatic structures in the residues are
the originators of the main mid-UV absorption of proteins (see Fig 4). Electromagnetic radiation
in the range 200 - 300 nm is defined as mid-UV. The upper part of this range from 250 nm was
termed the ‘simple region’ by Wetlaufer due to the small number of contributors to the intrinsic
protein absorbance in this region. These are the residues with aromatic structures: tryptophan,
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tyrosine, and phenylalanine. In the range 200 – 250 nm the absorption of the aromatic residues
and the peptide bonds overlap and also the residues containing sulphur absorb in this range.
The region below 200 nm is interesting for some applications because the peptide bonds absorb
here and particularly because of the relation to conformation.
In Fig. 5 - top, the absorption spectra of a wide range of proteins are displayed. With excep-
tion to the proteins containing a heme group, the spectra are rather similar. The main variance is
related to the amount of tryptophan present in the proteins. The two spectra in Fig. 5 - bottom,
represents main variation which can be expected from protein absorption spectra depending
mainly on the tryptophan/tyrosine ratio. Other factors such as the phenyl alanine content and
the direct environment of the chromophores will have less significant influence on the spectra
in the range 250 – 300 nm. However, the intrinsic absorption of proteins is influenced by the
environment of the chromophores. In Fig 6, two examples of a hypsochromic shift caused by
changes in the environment of tryptophan are shown. Fig. 6 - bottom compares the absorption
of tryptophan in water and the absorption of a protein very rich in tryptophan also dissolved in
water. As tryptophan residues are hydrophobic they are very often buried in the inside of the
three dimensional protein structure and hence not exposed to the hydrophilic solvent. As can
be seen, the water dissolved tryptophan spectra has undergone a significant blue shift which
is explained by the change from a predominantly hydrophobic environment to a hydrophilic
environment. The same is illustrated in Fig. 6 - bottom comparing the spectra of the peptide
mellitin embedded in a lipid membrane and free in aqueous solution. This effect can also be
observed in general when comparing the spectra of the three aromatic amino acids with the 27
protein spectra (see Fig. 4 - bottom and 5 - top). The aromatic amino acids exhibit a minimum
in their spectra between 230 nm and 240 nm where as the minima of the protein absorption
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spectra are shifted to the range 250 – 255 nm.
Extreme pH values will alter the protein absorption spectra due to changes in the ionization
stages of the chromophores (Benesch and Benesch, 1955). However, such extreme conditions are
not likely to be applied during protein purification. In general, it is expected that the protein
absorption spectra will not change significantly under the mild conditions usually present during
protein purification processes. This is in contrast to intrinsic protein fluorescence, which is
known to be much more environment sensitive than absorptivity.
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2 Research Proposal
A process for purification of therapeutic proteins must ensure very high and also very repro-
ducible quality. In order to reach this goal, a detailed control strategy is developed alongside
the purification process development. Recently, the interest in applying in process testing such
as in-line, on-line, and at-line analysis for process control has increased. The motivation behind
this is to ensure timely release of processed batches and limit the number of failed batches.
The number of failed batches is also closely related to process robustness. Therefore, process
robustness and the detailed relation between process parameters and product quality must be
addressed thoroughly during development of a protein purification process. As a consequence,
the focus of process development has been extended beyond the identification of (optimal) pro-
cess parameters and there is need for very extensive process characterization during process
development. In order to meet this need, the concept of high throughput process development
(HTPD) has evolved during the past decade. It is based on miniaturized, parallelized, and au-
tomated unit operations for protein purification which enables a high experimental throughput.
The concept of HTPD enables an intensified gain of process knowledge during the short time
frame available for process development. This is due to the high experimental throughput com-
bined with reduced protein material consumption which together increases the possible number
of experiments. In order to get beyond mere screenings, more sophisticated approaches such
as factorial designs, intelligent search algorithms, or mechanistic modeling are often includes in
the concept of HTPD. The larger amount of process knowledge gained in the miniaturized scale
will also reduce the process development work which must be performed at lab-scale. Many
of the unit operations applied for protein purification have already been established in a high
throughput format. However, to complete the successful establishment of HTPD, efficient an-
alytical tools must be in place as the overall throughput will otherwise decrease significantly.
An often applied strategy is to sacrifice analytical information for a higher throughput, however
this will limit the possible applications.
This thesis is proposed to address this analytical bottleneck in order to realize a high level
of analytical information without compromising throughput. The aim is to create a range of
original tools which will increase the efficiency using already applied core technologies for protein
analysis. Besides high throughput, the requirements for these analytical tools are robustness,
minimal sample preparation, high level of automation and low sample consumption. A further
objective of this thesis is to identify or invent analytical methods applicable for in-line, on-line
or at-line analysis for use in preparative liquid chromatography.
Analytical chromatography is very often applied for protein analysis during protein purifi-
cation process development. Hence, a particular focus of this thesis is to enable a more efficient
utilization of analytical chromatography systems and to ensure that these approaches will not
influence the quality of the obtained analytical information. Further, use of multivariate cali-
bration for analysis based on analytical chromatography will be investigated as an opportunity
to enhance speed without compromising the analytical quality.
For in-line process analysis, analytical methods based on spectroscopy are of particular ad-
vantage as they are non-invasive and can be performed in flow cells or with fiber optic probes.
Also for application within the concept of HTPD, analytical methods based on spectroscopy
are of great advantage. Modern spectrophotometers have been developed which can measure
samples in micro well plates. Hence, these photometers have a very high sample throughput.
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Therefore, another particular focus of this thesis will be on spectroscopic methods both for
in-line process analysis and high throughput protein analysis. The aim is to establish quantita-
tive and robust relationships between spectral informations and protein concentration or other
quality related information. As protein absorption spectra in the mid-UV range are particular
robust, these are thought to be of particular interest. A large investigation into the differences
and similarities of mid-UV protein spectra is of particular interest in order to challenge the
prevalent opinion that mid-UV absorption spectra lack specificity.
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1. A sub-two minutes method for monoclonal antibody-aggregate quantification
using parallel interlaced size exclusion high performance liquid chromatogra-
phy
This paper describes a method which enables maximum analytical throughput in size ex-
clusion chromatography. This is achieved by eliminating the lag time inherent in analysis
based on size exclusion chromatography. Special focus is on protein aggregate quantifica-
tion and it is demonstrated that a three fold reduction in analysis time is possible in the
particular case described.
Journal of Chromatography A, 1218 (2011) 9010-1018
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2. Rapid quantification of protein-polyethylene glycol conjugates by multivariate
evaluation of chromatographic data
This paper describes the use of multivariate calibration in the establishment of chromato-
graphic analysis where the achieved resolution is not sufficient for precise quantification of
all species based on traditional peak are integration. In the particular case, the samples
to be analyzed contained proteins with different numbers of poly ethylene glycol (PEG)
chains attached. The capability of performing precise quantification based on a low resolu-
tion analytical chromatography, enables faster analysis without loosing analytical quality
of the analytical data.
Journal of Chromatography A, 1257 (2012) 41-47
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3. A label-free methodology for selective protein quantification by means of ab-
sorption measurements
Biotechnology & Bioengineering, 108 (2011) 2661-2669
This paper describes the use of UV absorption spectra of proteins for selective protein
quantification in mixtures. A precise quantification method was successfully established
for a ternary protein mixture and shown to be valuable in a high throughput process
development context. The quantification method based on spectral data was much faster
compared to the quantification method based on analytical chromatogrphy otherwise used.
Further, it was shown that the quality of the analytical data was the same.
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4. Selective high throughput protein quantification based on UV absorption spec-
tra
Biotechnology & Bioengineering, doi: 10.1002/bit.24712
This paper presents a thorough investigation into protein absorption spectra. The work
includes 27 different proteins and their differences and similarities were uncovered and
quantified. A special focus was on the definition of a measure for spectral similarity and
its correlation with calibration precision.
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5. In-line analytics for preparative chromatographic separations based on multi-
variate calibration of protein spectra
Presented at the European Congress of Applied Biotechnology 2011, Berlin
This paper describes the possibility of applying in-line analytics for preparative chro-
matographic separations based on multivariate calibration of protein spectra. A proof of
concept study for separations of two binary protein mixtures is presented.
UV 225 Signal
lysozymeHU
lysozymeAV
Elution volume (mL)
protein spectra
Elution volume (mL)
31

A Sub-Two Minutes Method for
MAb-Aggregate Quantification using
Parallel Interlaced Size Exclusion HPLC
Patrick Diederich+, Sigrid K. Hansen+, Stefan A. Oelmeier+, Bianca
Stolzenberger, Ju¨rgen Hubbuch*
Institute of Engineering in Life Sciences, Section IV: Biomolecular Separation Engineer-
ing, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany
+ These authors contributed equally to this publication and appear in alphabetical order
* Corresponding author. Tel.: +49 721 608-2557; fax: +49 721 608-6240. E-mail address: juer-
gen.hubbuch@kit.edu
published the Journal of Chromatography A
33
3 PUBLICATIONS & MANUSCRIPTS
34
Abstract
In process development and during commercial production of monoclonal antibodies (mAb)
the monitoring of aggregate levels is obligatory. The standard assay for mAb aggregate quan-
tification is based on size exclusion chromatography (SEC) performed on a HPLC system.
Advantages hereof are high precision and simplicity, however, standard SEC methodology is
very time consuming. With an average throughput of usually two samples per hour, it neither
fits to high throughput process development (HTPD), nor is it applicable for purification pro-
cess monitoring. We present a comparison of three different SEC columns for mAb-aggregate
quantifi cation addressing throughput, resolution, and reproducibility. A short column (150
mm) with sub-two micron particles was shown to generate high resolution (∼ 1.5) and precision
(coefficient of variation (cv) < 1) with an assay time below six minutes. This column type was
then used to combine interlaced sample injections with parallelization of two columns aiming
for an absolute minimal assay time. By doing so, both lag times before and after the peaks
of interest were successfully eliminated resulting in an assay time below two minutes. It was
demonstrated that determined aggregate levels and precision of the throughput optimized SEC
assay were equal to those of a single injection based assay. Hence, the presented methodology
of paralell interlaced SEC (PI-SEC) represents a valuable tool addressing HTPD and process
monitoring.
Keywords: Monoclonal antibody, aggregates, Size Exclusion Chromatography,
high throughput analytics, interlaced injection, PI-SEC
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1 Introduction
Aggregate levels in monoclonal antibody drugs are a critical quality attribute due to their po-
tential immunogenicity [1, 2]. Aggregates of monoclonal antibodies are often the most abundant
product related impurity. The purification process needs to ensure that aggregate levels are re-
duced to an acceptable level in the final drug product. While the first two steps in a standard
mAb downstream process are readily capable of depleting three highly abundant process related
impurities, host cell protein, DNA, and water, the reduction of aggregate levels to acceptable
levels is often challenging. Thus, monitoring aggregate levels is critical in process development.
One way to reduce process development costs is to increase development throughput. Var-
ious process steps have been scaled down to fit into a high throughput process development
(HTPD) scheme [3–6]. Additionally, platform processes have been implemented for monoclonal
antibody based products, further reducing the efforts needed from process development down
to process verification [7]. These improvements have created an analytical bottleneck in process
development. To match throughput of the experimentation, reasonably short analysis times
need to be achieved.
Size exclusion chromatography (SEC) is the standard method for mAb-aggregate analysis.
The standard SEC assay with a throughput of two samples per hour [8, 9] does however not
suit a HTPD approach. Several measures are thus in the spotlight to increase throughput in
HPLC without changing the analytical technique as such: parallelization and interlacing sample
injection. While parallelization using multiple HPLC stations is currently the most often used
approach, it is for obvious reasons also the most expensive. Parallelization of multiple columns
on a single detector via column switching valves is a way to reduce parallelization cost and
has been successfully demonstrated [10]. Most often in this approach, the elution and the
regeneration of a chromatographic analysis are separated such that one column regenerates
while the other column performs an analysis [11]. In contrast to gradient elution, column
regeneration is however not necessary in SEC. Another approach to improve throughput is to
run a single column in an interlaced mode. In interlaced chromatography a sample is injected
onto the column before the preceding analysis has been completed. This approach requires
isocratic conditions. Farnan et. al [12] successfully demonstrated its use for aggregate analysis
of mAbs and were able to reduce assay time per sample by more than a factor of two from 30
minutes to 14 minutes.
Finally, HPLC equipment capable of higher back pressures has been implemented (most
often termed UHPLC) [13]. Shorter columns with smaller column volume and smaller particle
sizes can be used with this equipment, thus reducing assay time without sacrificing resolution.
While one of the most often used columns for mAb-aggregate analysis has a pressure limit of 7.2
MPa (Tosoh TSKgel 3000 SWxl), two new SEC columns suitable for higher back pressures of
24.1 MPa (Zenix SEC-250 (Sepax Technologies)) to 41.4 MPa (ACQUITY UPLC BEH200
SEC (Waters Corporation)) recently became commercially available.
In this paper, we compare mAb-aggregate analysis performed on these three SEC columns.
The columns are compared in terms of assay throughput, resolution, and precision. We demon-
strate the application of ACQUITY UPLC BEH200 SEC columns (Waters Corporation) in an
interlaced mode as well as by interlaced injections on two columns run in parallel. We demon-
strate how throughput can be increased by a factor of 10-15 compared to a standard analysis
using a TSKgel 3000 SWxl column. Advantages and disadvantages of the methodology are
discussed.
3 PUBLICATIONS & MANUSCRIPTS
36
1.1 Theory - Increasing Throughput by Interlacing and Parallelization
While the presented methodology can be applied universally to any type of SEC-column, differ-
ences arise in the use of (U)HPLC equipment and the actual pressure rating of the respective
SEC-columns and adsorbents. To implement the method developed in this study to its full
potential, a prerequisite lies in the use of an (U)HPLC system which is equipped with two inde-
pendent flow switching valves. An inlet valve directs the flow to the columns and autosampler
and an outlet valve directs the flow from the column outlets to the detector and waste. For max-
imum throughput two SEC columns can thus be run in parallel applying interlaced injections
on each of the two identical columns. The idea of parallel interlaced (PI-) SEC methodology is
to eliminate every region of a chromatogram which is not providing any relevant data (e.g. an-
tibody aggregate and monomer). In a first step, data of a single chromatographic SEC analysis
therefore serve as a benchmark for the estimation of analysis time and method development as
described in the following:
Single Injection
In figure 1 A and 2 A typical chromatograms of common mAb SEC analysis are displayed. The
chromatograms can be divided into four main phases. The first phase after sample injection
is the initial lag phase (tlag). The time span in which aggregate species and monomer elute is
referred to as information phase (tinf ). In this work, protein fragments are not considered as
species of interest and are not included in tinf . The third phase between monomer peak and the
eluting salt fraction is referred to as hold phase (thold). It is assumed that no protein elute later
than the salt fraction of the injected sample. The elution region of salt species is refered to as
tsalt. A single chromatogram of the sample material provides the user with the retention times
of every elution phase for the column used at the specific flow rate. The total time required for
the analysis of n samples can be stated as:
ttotal = n · (tlag + tinf + thold + tsalt) (1)
Given these retention times, the first step to increase analysis throughput is to eliminate tlag
from the resulting chromatograms as explained below.
Interlaced Injection
Farnan et al. [12] has described the methodology of interlaced SEC in detail. In a brief, the
methodology is based on injecting a subsequent sample before the ongoing analysis of a sample
has completed. The subsequent information phase begins immediately after the salt fraction of
the preceding sample has eluted. Figure 3 A and B show the transition from a mode of single
injection to interlaced injection. By the use of a second timebase (see section 2.2), a separate
control program for data aquisition (”program DAD”) facilitates distinct chromatograms for
each injection and corresponding sample. In figure 3 B it is demonstrated that the lag phase
can thus be eliminated from analysis. The total time required for the analysis of n samples can
be stated as:
ttotal = tlag + n · (tinf + thold + tsalt) (2)
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Figure 1: Schematic of PI-SEC
methodology applicable in the case of
tinf > thold. A: chromatogram of a
mAb sample analyzed in single injec-
tion mode. Using the elution phases
tlag, tinf , thold, and tsalt, a PI-SEC pro-
gram can be set up (B). In this case,
samples are injected alternately on two
columns, while the outlet valve di-
rects the flow from the column out-
let to the detector. .............................
..................................
Parallel Interlaced Injection
A further increase in throughput can be achieved when applying interlaced injections on two
columns which are operated in parallel. Starting from interlaced chromatogaphy, in parallel
interlaced SEC the assay time is further reduced by thold, as is demonstrated in figure 3 B
and C. Two switching valves are used to direct the flow alternately between autosampler,
two columns and the detector, thus enabling the elimination of tlag, thold and tsalt. In figure
3 D a scheme of the valve switching is displayed. The use of two columns and switching
valves require two distinct programs assigned to timebase 1, on which pumps, autosampler
and column compartment including the switching valves are controlled. The programs contain
the same commands, but differ in the direction of both valves switching. As for interlaced
chromatography, data aquisition is performed separately by using a second timebase (timebase
2 ) for the detector, now only recording phase tinf of each injected sample.
For programming PI-SEC, three possible cases need to be considered, since elution profiles
of a single injection analysis differ in tlag, thold and tsalt depending on column type and sample
material. For reason of simplicity, it is assumed that thold > tsalt, which is the common case in
SEC analysis of antibody samples.
Case-1. tinf > thold:
The first sample is injected on column 1 at:
t1 = 0 (3)
The second sample is injected on column 2 at:
t2 = t1 + tinf (4)
The subsequent samples are alternately injected on column 1 and column 2 at times:
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Figure 2: Schematic of PI-SEC
methodology applicable in the case of
tinf < thold. A: chromatogram of a
mAb sample analyzed in single injec-
tion mode. Using the elution phases
tlag, tinf , thold, and tsalt, a PI-SEC
program can be set up (B). In this
case, two samples are subsequently in-
jected per column before switching to
the second column. ............................
...................................
tn,inj = tn,inj−1 + tinf (5)
The total assay time for the analysis of n samples can hence be calculated by equation
6. This equation gives the theoretically possible increase in throughput which can be
gained via PI-SEC using one single detector.
ttotal = tlag + n · (tinf ) + thold + tsalt (6)
The outlet valve is switched as soon as the information phase of a sample from one
column has passed the detector. At that time, the salt peak has completely eluted
from the other column. Samples are alternately injected on the two columns and ana-
lyzed without any interference of eluting salt fractions. As an example, figure 1 shows
a schematic drawing of PI-SEC methodology for the case of thold < tinf .
Case-2. k · tinf < thold:
If k ≥ 1, one or more informational phases fit into thold and k additional injections
(rounding down of k to whole numbers) on one column become feasible before switch-
ing to the second column. The injection times and the time needed for the analysis of
n samples can be estimated using the same equations 3 - 6 as given in case one. Figure
2 shows a schematic drawing of the PI-SEC methodology applied for a case 2 elution
profile where 1 < k < 2. Now, two salt peaks elute from one column within the time
two information phases elute from the other column.
Although time benefit is the same as in case one, it should be noted that in this
mode proteins of multiple, subsequently injected samples pass the salt fraction of the
preceding injected samples, whereas for case one the salt fraction of each sample always
elute earlier from the column than does the information phase. Multiple injections on
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one column is further only applicable, if no species of lower molecular weight than the
monomer species is present in the sample material. Otherwise the species of lower
molecular weight will elute within the information phase of the subsequent sample
injected on the same column.
In the case that k < 1 and the outlet valve is switched instantly after the information
phase of a sample from one column has passed the detector, the salt fraction of the pre-
ceding sample has not eluted yet from the second column. Therefore, some additional
time (tadd) must be added before switching the outlet valve. The sum of tadd + tinf
needs to be greater than thold + tsalt. The time needed for the analysis of n samples
can be estimated using equation 6, while including tadd (9). This delay needs also to be
factored in the injection times of the interlaced mode of each column. When the first
injection at t1 is performed, the second injection takes place at:
t2 = t1 + tinf + tadd (7)
The injection time of sample n can be hence given by:
tn,inj = tn,inj−1 + tinf + tadd (8)
The total assay time for n samples can be calculated using:
ttotal = tlag + n · (tinf + tadd) + thold (9)
From a practical aspect it should be mentioned that, if tinf is slightly smaller or exactly
equals the sum of thold + tsalt, the outlet valve is switched just when salt is detected or
just arrives at the detector. The baseline determination and an autozero processing of
the absorbance signal is hence affected and might lead to unprecise peak integration.
Regarding all described scenarios case one marks the optimal condition for PI-SEC since
information phases of samples injected alternately on two columns neither interfere with eluting
salt fractions nor are additional times required. With an increasing ratio of tinf/thold, the
benefit of using two columns in parallel over interlaced injection decreases. For the purpose
of method robustness, in any of the above described cases additional time for switching the
inlet and outlet valves should be implemented: Switching the inlet valve should occur a few
seconds before the injection takes place and switching of the outlet valve should occur a few
seconds before the high molecular weight species elute. Thus, baseline determination and peak
integration become more precise. To set up the control program, sampling and washing times
need to be taken into account. The duration of sampling and washing depends strongly on the
used (U)HPLC equipment and might significantly slow down the assay if it exceeds the duration
of the information phase. Furthermore, differences in column packing and hence retention times
need to be considered.
2 Materials & Methods
2.1 SEC columns
SEC columns from three vendors were used in this work: 1. TSKgel 3000 SWxl (Tosoh Corpo-
ration, Tokio, Japan) 2. ACQUITY UPLC BEH200 SEC (Waters Corporation, Milford, MA,
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Figure 3: Three modes of operating SEC analysis are displayed. Based on single run chromatograms
(A) throughput can be improved by interlacing sample injections (B) on one SEC column. By using
a second timebase (timebase 2 ) for data acquisition, a dedicated chromatogram is generated for every
sample injection. Each timebase is controlled by separate programs. Using a second column run in
parallel and two timebases (C), throughput can pushed to its theoretical maximum by performing
interlaced injections on both columns. Hereby, two programs on timebase 1 are implemented differing
only in the switching direction of the switching valves. A schematic of the configuration of two six-port-
valves (D) demonstrates the switching procedure which has to be implemented in the control programs
1 and 2.
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USA) 3. Zenix SEC-250 (Sepax Technologies, Newark, DE, USA). Columns were fitted with
0.2 µm inlet filter (Opti-Solv EXP , Optimize Technologis, Oregon City, OR, USA). In table
I the column properties are listed. The columns differ in macroscopic as well as microscopic
dimensions.
Table I Specifications of the HPLC SEC columns used in this study.
vendor column pore particle maximum volume
description dimension size size pressure column void
ACQUITY UPLC BEH200 SEC 4.6x150 mm 200 A˚ 1.7 µm 41.5 mPa 2.5 mL 1.97 mL
Zenix SEC-250 4.6x250 mm 300 A˚ 3.0 µm 24.1 mPa 4.2 mL 3.45 mL
TSKgel 3000 SWxl 7.8x30 0mm 250 A˚ 5.0 µm 7.8 mPa 14.3 mL 12.23 mL
2.2 UHPLC setup
An UltiMate3000 RSLC x2 Dual system from Dionex (Sunnyvale, CA, USA) was used for
UHPLC analysis. The system was composed of two HPG-3400RS pumps, a WPS-3000TFC-
analytical autosampler and a DAD3000RS detector. The autosampler was equipped with a
sample loop of 5 µl or 20 µl, respectively. The volume of the injection needle was 15 µl, the
syringe size was 250 µl. In all experiments, full loop injections were performed. The system
included a TCC-3000RS column thermostat to enclose two columns, which were connected to
two six-port column switching valves. The inlet valve directs the flow between autosampler
outlet and column inlets, hence controlling to which column a sample is injected. The outlet
valve directs the flow between column outlets and UV-detector, hence controlling from which
column outlet the UV signal is measured. All column experiments were conducted at 25 ◦C.
For SEC analysis performed in interlaced and parallel-interlaced mode, the system was split in
two virtual parts by using two separate timebases. Timebase 1 controlled pumps, autosampler,
valves and column compartment and Timebase 2 controlled the UV detector. The two timebases
were physically linked by connecting a relay assigned to timebase 1 with an input assigned to
timebase 2. Switching of the relay in timebase 1 triggered an input signal in timebase 2. This
input signal was then used to trigger the UV signal acquisition. By this setup, it was possible
to record the information phase of each sample separately.
2.3 Software
Matlab2010a (The Mathworks Natick, ME, USA) was used for data analysis. Chromeleon (6.80
SR10) was used to control the UHPLC equipment and to integrate the elution peaks in the chro-
matograms. The Chromeleon software was extended to include two timebases.
2.4 Buffer and Sample
SEC analysis were performed using a 0.2 M potassium phosphate buffer at pH 6.2 containing
0.25 M potassium chloride. Buffers were filtered through 0.2 µm filters (Sartorius, Germany)
prior to use. When two pumps were used simultaneously (parallel-interlaced protocol), the same
buffer preparation was apportioned in two bottles. A proteinA pool of a CHO expressed IgG
was used as mAb sample. The concentration was set to a concentration of 1 g/L by dilution
with dH2O.
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2.5 Aggregate Level and Chromatographic Resolution
For each single injection run, the aggregate level and the resolution was determined. For all
interlaced and parallel-interlaced runs only the aggregate level was determined. The aggregate
level was defined as the percentage of the species in the mAb sample eluting prior to the
monomer. The achieved chromatographic resolution of the mAb monomer and the smallest
aggregate (dimer) was calculated based on the EP norm:
R = 1.18 · tmonomer − tdimer
W50%,monomer +W50%,dimer
(10)
2.6 Single Injection SEC Protocols
The TSKgel column was loaded with 20 µL of sample and the analysis was run at flow rates
between 0.235 mL/min and 1.5 mL/min (30 - 188 cm/h). The ACQUITY column was loaded
with 5 µL of sample and run at flow rates between 0.05 mL/min and 0.5 mL/min (18 - 181
cm/h). The Zenix column was loaded with 5 µL of sample and run at flow rates between
0.05-0.96 mL/min respectively (18 - 347 cm/h). The exact flow rates are listed in table II.
2.7 Interlaced SEC protocol
For interlaced SEC experiments the chromatography system was split in two virtual parts as
described in section 2.2. It should be noted, that this is not a necessary prerequisite in interlaced
chromatography, but rather a convenience for the experimenter. By splitting the instrument
and running dedicated programs for UV signal acquisition, the relation of chromatogram and
injected sample is facilitated. The methodology described in section 1.1 was applied to the use
of ACQUITY columns. A single chromatographic run at a flow rate of 0.4 ml/min was used to
determine the initial lag phase (tlag) (see fig. 1 A).
In the adapted method, the data acquisition program on timebase 2 was triggered by
switching a relay on timebase 1 at t = tlag after injection. The withdrawal of the subse-
quent sample (pulled-loop mechanism) was triggered 51 seconds prior to injection by using
the ”PrepareNextSample”- command. This avoided additional hold phases between subsequent
control programs.
2.8 Parallel-Interlaced SEC Protocol
To improve throughput further, a second column was run in parallel to the first column using
two switching valves directing the flow to the columns and to the detector, respectively. The
eluate of one column was directed to the waste right after the monomer peak has passed the
detector. The eluate of the second column was then directed to the detector, while the salt
peak eluted from the first column into the waste. By running both columns simultaneously in
an interlaced mode, the maximum possible throughput of the system was realized (section 1.1).
In this work, two ACQUITY columns were used at a flow rate of 0.4 mL/min. The time for
sample withdrawal was adjusted to 27 seconds (pulled-loop mechanism). Thoroughly washing
of the sample loop and the injection needle was set to be performed within 90 seconds.
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2.9 Aggregate Spiking Studies
Aggregate spiking studies were conducted in order to evaluate the linearity of aggregate deter-
mination of the presented parallel-interlaced methodology. Two solutions containing different
levels of aggregate were mixed to control the level of aggregate in the samples. In order to obtain
a solution with a high aggregate content, aggregate was isolated from the proteinA pool. This
was done by loading the mAb sample onto a Poros 50 HS (GE Healthcare, Germany) column.
Before loading the column, the mAb sample had been adjusted to a conductivity of 15 mS/cm
and a pH of 5.5. These conditions had been found to provide high selectivity for mAb aggregates
compared to mAb monomer. The elution was performed with a sodium chloride gradient from
10-150 mM in 20 mM MES buffer at pH 5.5. The eluate was collected in fractions, analyzed by
SEC and merged to create an aggregate pool with approximately 50 % aggregate. Seventeen
aggregate levels were tested ranging from 2.1 to 48.7 %. The samples were first analyzed on
two different ACQUITY columns in single injection mode, where each sample was measured
sixfold. Subsequently, the presented parallel-interlaced assay was applied, using the same two
columns and the same samples which were measured sixfold each. The results were compared
in terms of coincidence of the linear regression between expected aggregate level and aggregate
level determined via the different approaches.
3 Results & Discussion
SEC columns from three different vendors with different particle size, pore size, and length were
applied for mAb aggregate quantification. In contrast to the TSKgel column, the ACQUITY
and the Zenix columns have entered the market recently. The TSKgel column has been on
the market for almost 25 years and a literature survey revealed a marked preference for this
particular column in relation with mAb analysis (data not shown). The chosen columns were
compared in terms of generated chromatographic resolution, throughput and precision of ag-
gregate quantification. Based on the results, the best suited column and flow rate was chosen
and used to establish a in throughput optimized assay by combining interlaced injections with
parallel operation of two SEC columns.
3.1 Single Injections
Three different columns were used to analyze identical mAb samples. Figure 4a shows all three
resulting chromatograms. The applied flow rates were 108 cm/h for the ACQUITY, 116 cm/h
for the Zenix column, and 126 cm/h for the TSKgel column. For comparability, the chro-
matograms were normalized with respect to void volume of the respective column (figure 4b).
The void volume of each column was defined as the elution volume of the sample buffer. These
are listed in table I.
The normalized chromatograms revealed similar elution patters for all columns in which the
mAb species eluted over a range from approximately 0.45 to 0.85 void volumes. The elution
order, based on normalized elution volume of the monomer species from the three different
columns (VACQUITY < VTSKgel < VZenix) correlated with the decreasing pore size of the column
matarial (ACQUITY: 200 µm, TSKgel: 250 µm, Zenix: 300 µm). The elution profiles generated
by the Zenix and the TSKgel column exhibited a more widely stretched elution of the aggregate
species. At very low flow rates, these two columns also revealed a third aggregate species
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Figure 4: a: Overlay of single injection chromatograms of the mAb sample (1.0 g/L) analyzed on three
different SEC columns. b: For comparability, elution volumes were normalized to column void volumes.
in the mAb sample which eluted in between the two main aggregate species (data not shown).
However, if an analytical assay aims for the total aggregate level, a resolution of single aggregate
species is not necessary. In such a case, the most important parameter is the resolution of the
smallest mAb aggregate species (dimer) and the mAb monomer. Hence, in the following the
term resolution will refer only to the resolution of mAb monomer and dimer species.
3.1.1 Aggregate Levels and Precision
The determined resolution, aggregate level, and coefficient of variation (cv) for each applied flow
rate and column are listed in table II. The columns were shown to generate different results
regarding aggregate level, even though the same mAb sample was analyzed. Using the TSK
column, the highest and most stable aggregate level (4.80 % ± 0.08) over the tested range of
flow rates was determined. Using the ACQUITY column, a lower mean aggregate level was
determined (4.17 % ± 0.44) and further the determined aggregate levels exhibited an increase
with increasing flow rate (3.79 % - 5.02 %). However, the precision resulting from each tested
flow rate was comparable to the accuracy obtained with the TSKgel column (cvmean,TSKgel =
0.91, cvmean,ACQUITY = 0.87). The overall aggregate level determined using the Zenix column
(4.20 % ± 0.35) was similar to the one obtained with the ACQUITY column, however the
accuracy of the results was lower compared to both other columns (cvmean,Zenix = 1.38). As
for the ACQUITY column, the aggregate level determined with the Zenix column exhibited
an increase with increasing flow rate (3.69 % - 4.54 %). For all columns, a tendency of higher
precision at medium flow rates was observed.
3.1.2 Resolution vs. Analysis Time
The main objective of the presented work, was to establish an ultra-rapid SEC assay for mAb
aggregate quantification. Due to the different column dimensions, the correlation between
resolution and flow rate does not transmit directly to analysis time. To give an overview of the
direct relation between analysis time and chromatographic resolution, the resolution generated
for each flow rate and column was plotted as a function of the required time per analysis (figure
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Table II: Aggregate levels determined for
a mAb sample using three different columns.
Each column was operated at several dif-
ferent flow rates. All displayed results are
based on six replicates.
TSKgel 3000 SWxl
Flow rate Aggregate cv resolution
(cm/h) (mL/min) (%) (%) (-)
30 0.235 4.74 1.91 1.85
44 0.352 4.87 0.85 1.77
63 0.50 4.87 0.60 1.71
94 0.75 4.84 0.27 1.59
126 1.00 4.83 0.52 1.50
157 1.25 4.79 0.48 1.41
188 1.50 4.64 1.75 1.34
ACQUITY UPLC BEH200 SEC
Flow rate Aggregate cv resolution
(cm/h) (mL/min) % % (-)
18 0.05 3.79 1.94 1.66
27 0.075 3.90 1.00 1.60
36 0.10 3.90 0.99 1.61
72 0.20 4.00 0.48 1.56
108 0.30 4.16 0.27 1.52
144 0.40 4.36 0.94 1.47
181 0.50 5.07 1.52 1.45
Zenix SEC-250
Flow rate Aggregate cv resolution
(cm/h) (mL/min) % % (-)
18 0.05 3.69 2.33 1.35
27 0.075 3.96 0.97 1.33
36 0.10 4.11 0.58 1.30
116 0.32 4.28 0.97 1.14
231 0.64 4.62 1.53 1.01
347 0.96 4.54 1.91 0.92
5). The evaluation was performed in sequential mode, thus time per analysis equals time needed
for processing a single column volume (CV). In generel, the decrease in resolution correlated
with the particle size of the column material. We found that at assay times above 20 min, the
TSKgel column achieved the highest resolution of the columns tested. The resolution achieved
under these conditions ranged from 1.59 to 1.85. However, in most cases, a resolution of 1.5 is
sufficient for precise quantification. Hence, the high resolution achieved by the TSKgel column
at the lower end of the tested flow rates will in some cases be disadvantageous as an unnecessary
low throughput is the consequence of the achieved yet dispensable resolution. At lower assay
times (increased flow rates) the resolution achieved with the TSK column was shown to decrease
faster compared to the ACQUITY column. Of all columns, the ACQUITY column was shown
to generate the highest resolution at assay times below 20 min. This finding correlates with the
smaller particle size of the ACQUITY column. The tested Zenix column was outperformed by
the TSKgel and ACQUITY columns with respect to resolution at all tested assay times. One
advantage of the Zenix column was the potentially lower assay time, but the low resolution
under these conditions were shown to generate imprecise results (see table II) . However, assay
times down to 13 min generated adequate precision (cv < 1) despite the low resolution. Hence,
taking the relative low cost for the Zenix column compared to the TKSgel and the ACQUITY
column into consideration (which exhibits a factor of 1:1.5:2), this column could pose a favorable
alternative to the otherwise comprehensive use of the TSKgel column.
Sufficient resolution (∼ 1.5) and precision (cv < 1) was shown feasible with the ACQUITY
column even at very low analysis times. This clearly favours the ACQUITY column for develop-
ment of a high throughput parallel-interlaced SEC assay. A flow rate of 0.4 ml/min was chosen,
both to guarantee sufficient accuracy and also not to operate the column close to maximal flow
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Figure 5: Achieved chromato-
graphic resolution for each tested
column displayed as a function of
the analysis time. Each data point
represents the mean value of six
measurements. ............................
...................................
rate.
The findings presented above are based on measurements performed with only one column
per column type. Hence, the conclusions do not take batch and packing variability into consid-
eration. This influence is shown in the studies below. Further, a buffer optimization was not
in the scope of this work and changes in performance under other buffer conditions can not be
ruled out.
3.2 Interlaced SEC
Twenty five injections of the same load material were performed on three ACQUITY columns
in interlaced mode. Average analysis time per sample was 3:27 minutes at a flow rate of 0.4
ml/min. Figure 6A shows the resulting A225 trace from the detector. It can be seen that
the initial lag time was successfully cut from the analysis time. In this mode of operation
1.43 samples were analyzed per column volume. While aggregate levels resulting from all three
column were in the same range and normally distributed around their mean, pairwise t-tests
(α = 0.01) showed that all results differed statistically significantly from one another. The
first column resulted in a mean aggregate level of 5.08 % with a standard deviation of 0.04.
The second column yielded mean 5.02 % with a standard deviation of 0.05. The third column
yielded mean 4.91 % with a standard deviation of 0.04.
By interlacing injections and switching to a column of smaller volume and particle size, the
assay time was reduced from 14 minutes reported by Farnan [12] to 3:27 minutes. The obvious
advantage of using interlaced injections lies in the improved throughput. However, special care
has to be taken in order to correctly relate sample and chromatogram. By splitting the instru-
ment into two virtual parts (timebases) a comfortable solution to this problem can be achieved.
While throughput was increased, there was still room for optimization. First, column utilization
is not optimal as only the initial lag phase is eliminated by interlaced injections. Second, the
next sample was not injected until 15 seconds after the salt fraction of the preceding sample
had eluted.
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Figure 6: A: A225 absorption data of
two injections run in interlaced mode
on the ACQUITY column. The dashed
line represents the limit between the two
samples. 1.43 samples could be analyzed
per CV in this mode of operation. B:
A225 absorption data of four injections
run in parallel-interlaced mode on two
ACQUITY columns. The dashed lines
represent the moments of switching the
column outlet valve to the detector for
the subsequent sample. Separate result
files are generated for each sample as
delimited by the dashed lines. Equally
colored lines represent samples analyzed
over the same column. Three samples
were analyzed per CV in this mode of op-
eration .............................................
..............................................
..............................................
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3.3 Parallel-Interlaced SEC
Program Parameters
By parallelization of two ACQUITY columns operated with interlaced sample injections, chro-
matograms containing only the aggregate and monomer areas could be generated. As described
in chapter 1.1, the control program was set up based on a single run at a flow rate of 0.4
ml/min. The operation commands of the Chromeleon software and the corresponding times
in the control programs of timebase 1 and timebase 2 are summarized in table III. tlag was set to
2:00 minutes. tmininf , the minimal possible analysis time was 1:12 minutes. Twenty-four seconds
were added to tmininf to make the method more robust against changes in sample composition.
tinf used for programming the method was thus 1:36 minutes. The determined thold was 1:18
minutes. A sequence of samples was first started with a dummy run in which the first sample
is injected but no protein elutes. DAD data acquisition thus generated a blank sample. Imme-
diately after DAD data acquisition has ended, the outlet valve was switched. Fifteen seconds
were added to the method to ensure a stable baseline after switching the outlet valve (t1add =
0:15). Next, the inlet valve was switched. Three seconds were added to the method to flush
the autosampler prior to injection (t2add = 0:03). Triggering the data acquisition was performed
three seconds after the sample injection by using the following commands: after the Inject
command triggered sample injection in timebase 1, a Relay.State = ON command switched a
relay which was connected to an input via cable. A wait Input.State = ON as first command
in the control method for timebase 2 triggered the start of this control method and thus of DAD
data acquisition as soon as relay 3 was switched. 1:27 minutes later the next sample withdrawal
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was started using the PrepareThisSample command. 0:09 minutes afterwards, DAD data ac-
quisition was stopped thus closing one cycle of sample injection and detection. The process of
sample withdrawal took 27 seconds and was performed during the last nine seconds of tinf of
the preceding sample and the t1add and t
2
add after switching the outlet valve and inlet valve.
In general, the operating speed of the autosampler was found to be an important factor
when programming the control method. Slower autosampling equipment might hinder the im-
plementation of the method. Compared to the data presented, faster autosampling procedures,
for example by using a inline split-loop autosampler instead of the used pulled-loop would take
the method closer to its theoretical minimum of 1:12 minutes.
To analyze a batch of samples, two batch files were created, one for each timebase. The
batch file for timebase 1 contained two different control programs with each used for every other
sample. The two control programs were equal but for the valve switching commands. The batch
file for timebase 2 consisted of a sequence of the DAD control program. The two batch files
were started simultaneously.
Method Performance
Fifty injections (25 on each column) of the same mAb load material were performed in parallel-
interlaced mode. The analysis time for this batch was 1:57 minutes per sample. Figure 6B
shows the resulting detector signal at a wavelength of 225 nm of four consecutive samples.
Compared to the standard analytic (single injections, TSKgel column), throughput was im-
proved by 10-15x. Compared to single injections on the same column type, throughput was
increased approximately 3x. In accordance to equation 6 the analysis time per sample for n
samples can be calculated as follows:
tanalysis =
tlag
n
+ (tinf +
∑
tadd) +
thold
n
(11)
which in our case amounts to
1:57 =
2:00
50
+ (1:36 + (0:15 + 0:03)) +
1:18
50
(12)
It is obvious that tlag and thold do not contribute substantially to the overall analysis time
when running the columns in parallel interlaced mode.
A statistical analysis of the results was performed and two data points differing more than 3
standard deviations from the mean value were excluded from further analysis. Average aggre-
gate content detected was 5.03% with a standard deviation of 0.26 This rather large standard
deviation was due to differing results from the two separate columns used. Mean aggregate level
determined on the first column was 5.27% with a standard deviation of 0.06. Mean aggregate
level determined on the second column was 4.78% with a standard deviation of 0.05. While
both columns yielded aggregate levels normally distributed around their mean value, results
from both column differed statistically significantly as determined by a t-test (p < 0.1%).
The presented method was shown to achieve large improvements of throughput for the
particular analysis investigated. Certain prerequisites for achieving these improvements for any
given chromatographic assay should be noted. First, the method works for isocratic elutions
only, which is the case for SEC and some IEC/HIC analytics. Second, the improvement in
assay throughput is related to the ratio of the information to the non-information phases of the
chromatogram as only those parts containing no valuable information can be eliminated from
the chromatogram. In the case described here, the information phase was approximately 24%
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Table III Control parameters used to control timebase 1 (TB1; autosampler, pumps, column
compartment including switching valves) and timebase 2 (TB2; DAD). The commands for injecting
five samples are shown. The initial flow path was: sampler → column 1 → DAD. Column “Time”
shows the actual time during the analysis. Columns “TB 1” and “TB 2” show the time points
programmed into the control programs for timebase 1 and timebase 2. The “action” columns
adjacent to the “TB 1” and “TB 2” columns contain the commands used at the corresponding
time point. Column “Sample” shows the time during which a sample is on a specific column. The
first data acquisition on timebase 2 generates a chromatogram (’dummy #’) that only contains
the tlag of the first sample. (The two control programs of timebase 1 differ only in switching valve
commands. The data acquisition program on timebase 2 is started by switching a relay ON.)
Time Sample TB 1 Action Flow path Action TB 2
00:00 -0:27 Prepare sample #1
00:27 0:00 Inject + Start Wash Wait Input.state = ON 00:00
00:30 0:03 Relay.State = ON Data Acquisition On
01:54 1:27 Pump Acquisition OFF
01:57 1:30 method end dummy #
01:57 -0:27 Prepare sample #2
02:06
sample
#1 /
column 1
-0:18 switch outlet valve column 1 → DAD Data Acquisition Off 1:36
02:12 method end 1:42
02:21 -0:03 switch inlet valve sampler → column 2
02:24 0:00 Inject + Start Wash Wait Input.state = ON 00:00
02:27 0:03 Relay.State = ON Data Acquisition On
03:51 1:27 Pump Acquisition OFF
03:54 1:30 method end sample #1
03:54 -0:27 Prepare sample #3
04:03
sample
#2 /
column 2
-0:18 switch outlet valve column 2 → DAD Data Acquisition Off 01:36
04:09 method end 01:42
04:18 -0:03 switch inlet valve sampler → column 1
04:21 0:00 Inject + Start Wash Wait Input.state = ON 00:00
04:24 0:03 Relay ON Data Acquisition On
05:48 1:27 Pump Acquisition OFF
05:51 1:30 method end sample #2
05:51 -0:27 Prepare sample #4
06:00
sample
#3 /
column 1
-0:18 switch outlet valve column 1 → DAD Data Acquisition Off 01:36
06:06 method end 1:42
06:15 -0:03 switch inlet valve sampler → column2
06:18 0:00 Inject + Start Wash Wait Input.state = ON 00:00
06:21 0:03 Relay.State = ON Data Acquisition On
07:45 1:27 Pump Acquisition OFF
07:48 1:30 method end sample #3
07:48 -0:27 Prepare sample #5
07:57
sample
#4 /
column 2
-0:18 switch outlet valve column 2 → DAD Data Acquisition Off 01:36
08:03 method end 01:42
08:12 -0:03 switch inlet valve sampler → column 1
08:15 0:00 Inject + Start Wash Wait Input.state = ON 00:00
08:18 0:03 Relay.State = ON Data Acquisition On
09:42 1:27 Pump Acquisition OFF
09:45
sample
#5 /
column 1
1:30 method end sample #4
of the entire chromatogram. Samples and analysis tasks making use of a larger portion of the
chromatogram are amenable to the methodology as described in section 1.1 but might not yield
throughput improvements as high as those reported here.
Reliability, robustness, and quantitativeness are the hallmarks of analytical SEC chromatog-
raphy for mAb-aggregate quantification. Thus, it is preferred over other, even faster analytical
methods such as capillary gel electrophoresis. The presented methodology increased sample
throughput to an extend that it matches the speed of high throughput experimentation with-
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out changing the robust, underlying analytical principle. More detailed studies of aggregation
and aggregate depletion during process development and production of mAb based pharmaceu-
ticals can thus be performed.
3.4 Aggregate spiking studies
Aggregate spiking studies resulted in a linear response of the detected aggregate level to the
expected aggregate level in the sample throughout the entire range tested (2.1% to 48.7%). The
linear regression of measured aggregate level versus expected aggregate level were compared
for the two separate columns used and two modes of operation (single and parallel-interlaced
injection mode). The linear regression results were found to coincide, slope and intercepts were
found to be statistically not different. The overall regression of expected versus measured value
was resulted in aR2 value of 0.9993 with an intercept fixed at 0 and a resulting slope of 1.01. This
underlines our conclusion that the method presented herein can replace the standard method
of running SEC columns for mAb-aggregate analysis and that the column used is well suited
for the analysis task investigated. In theory, increasing aggregate levels could have increased
the aggregate peak area to an extend where either monomer-aggregate peak resolution would
decrease or where column valve switching times might have had to be adjusted. However, neither
was found leading to the conclusion that the presented method is robust regarding aggregate
levels of up to 48.7%. Aggregate levels below 2.1% were not investigated owing to the sample
material at hand. However, the authors find no reason to believe that lower aggregate levels
would pose a problem to the method.
4 Conclusion
In case of total mAb aggregate quantification, we find the ACQUITY column to be the best
suited choice of the tested columns, as it enables more than a two fold improvement in through-
put when compared to the TSKgel column (assay time comparison at a resolution of 1.5, see
figure 5 and table II). Further, due to the relatively low influence of flow rate on the separation
which was found for the ACQUITY column, assay throughput can be increased further without
compromising resolution significantly. The ACQUITY column also offers the benefits of lower
buffer consumption and lower sample volume, latter being of great importance when performing
HTPD.
A new methodology to improve throughput for SEC mAb analysis applied in biopharmaceu-
tical science was demonstrated in this paper. By combining interlaced injections with parallel
operation of two columns, near optimum utilization of SEC columns for the quantification of
monomer and aggregate of a monoclonal antibody solution was achieved. Assay time was re-
duced to 1:57 minutes per sample as compared to 20-30 minutes using standard analytical
protocols. Resulting aggregate levels were found to be comparable between different columns
and different modes of operation. As an added benefit, heterogeneity between separate columns
is factored into the results by using this method. With analysis times in the range of 2 min-
utes per sample the method presented in this paper is well suited for current high throughput
pharmaceutical process development and process monitoring.
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Abstract
Size exclusion chromatography (SEC) is often applied for characterization protein-polyethylene
glycol (PEG) conjugates regarding the number of attached PEG chains (PEGamers). SEC
analysis is advantageous as it is precise, robust, and straightforward to establish. However,
most SEC based assays have a maximal throughput of a few samples per hour. We present a
strategy to increase analytical throughput based on combining a short column with a fast flow
rate, and finally multivariate calibration in order to compensate for the resolution lost in the
trade off for speed. Different multivariate approaches were compared and multilinear regression
was shown to result in the most precise calibrations. Further, a dynamic calibration approach
was developed in order to account for changes in column performance over time. In this way,
it was possible to establish a highly precise assay for protein PEGamer quantification with a
throughput of 30 samples per hour.
Keywords: multivariate calibration; high throughput analytics; high throughput
experimentation; PEGamer quantification; protein PEGylation; high throughput
process development
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1 Introduction
Attaching polyethylene glycol (PEG) polymer chains to proteins (PEGylation) has been shown
to improve their pharmacokinetics. The increase in size reduces renal clearance of the therapeu-
tic and there is proof of immunogenicity and antigenicity being reduced by PEGylation [1, 2].
Further, solubility of hydrophobic proteins can be increased by PEGylation [3]. The PEGyla-
tion process determines the PEGamer distribution and positions of the PEG molecules attached
to the protein. If random PEGylation is performed, the product of the reaction will be very
heterogeneous. This poses a problem in a regulative environment which demands defined prod-
ucts of extremely high homogeneity. In general, there are two ways to reach a homogeneously
PEGylated product. Either the product mixture of the random PEGylation can be purified to
contain only the desired PEGylated species or site specific PEGylation can be performed.
In our lab, small scale PEGylation experiments performed automated on liquid handling
stations have been established. This enables high throughput screenings of PEGylation process
parameters and is a part of a general trend where automated high throughput experimentation
(HTE) is applied for high throughput process development (HTPD) of biologicals [4]. For
the evaluation of the performed experiments to stand in relation to experimental speed when
performing HTE, the analytical throughput must match the experimental throughput. In some
cases this comes easily, for instance if the evaluation of screenings performed in HTE mode can
be based merely on univariate spectroscopic measurements such as total protein quantification
via UV absorption measurements [5–7]. If selective or specific quantification is necessary, other
methods have to be considered. In the case of quantitative separation of protein PEGamers, size
exclusion chromatography (SEC) is widely applied. However, for SEC based assays to match
the speed of HTE, the analysis time per sample must be reduced to merely a few minutes.
SEC is a standard method for selective and specific quantification of proteins. If exact
quantification is the primary objective, most analysts will seek to achieve high resolution (R
> 1.5) of the components. If a short analysis time is the primary objective, faster flow rates
and/or shorter columns can be applied, however, at the expense of resolution. One approach to
increase analytical speed without losing resolution is the interlacing of injections and/or parallel
operation of two columns on a chromatographic system [8, 9]. When interlaced injections are
performed in SEC analysis, the result is elimination of initial lag time between sample injection
and start of elution. If interlaced injections are combined with parallel operation of two columns,
the waiting time post elution of the smallest sample molecule of interest can be reduced or even
eliminated. Thus, in favorable situations, analysis time per sample can be reduced to the time
span in which the molecules of interest elute.
The separation of protein PEGamers using SEC poses a very challenging task, as the relative
increase in molecular size decreases for each additional PEG molecule attached to the protein
[10]. A size based chromatographic separation of native protein and mono-PEGylated species
might be achieved effortlessly, however a resolution of the higher protein PEGamers will become
increasingly difficult.
Our proposition is that for analytical purposes the degree of separation necessary for correct
quantification can be decreased significantly by applying alternative methods for the evaluation
of chromatographic data. This idea is based on the assumption that overlapping elution of
different species will result in a chromatogram which is a linear superposition of the signals of
each single analyte. Therefore, a linear multivariate correlation between elution profile (chro-
matogram) and amounts of the different components in the respective samples can be expected.
This, of course, presumes that the amount of the analytes does not influence the elution profile.
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In the linear range of adsorption, this assumption would apply as peak shape is a function of
the chromatography system (dead volumn, column packing ect.) and protein characteristics
(adsorption and diffusion) but not of protein concentration. Further, the separation mechanism
of SEC does not depend on direct interaction with the column material and thus it is not ex-
pected that different load concentrations should cause a non-linear change of the elution profile.
If the linear correlation between analyte concentration and elution profile is given, it should be
possible to calibrate a multivariate regression model based on one chromatogram of each pure
component and one defined mixture of all components. Such a multivariate regression model
could then give precise determinations of sample composition despite low chromatographic res-
olution of the sample components.
The presented work describes how multivariate calibration can be used to gain quantitative
results of high quality from low resolution chromatograms. By doing so, faster analysis times
are achievable through application of short columns and high flow rates that would otherwise
be avoided due to inferior separation performance.
In general, a balanced ratio of analytical and experimental time allows a more efficient use
of the HTE platform. The goal was to achieve an assay time of maximum two minutes. This
would facilitate a 24 hour experiment-analysis cycle for PEGylation screenings in 96 well HTE
format, where screening experiments which are performed during day time can be analyzed over
night. Further, fast assays can be useful for PEGylation reaction monitoring and subsequent
purification process monitoring.
2 Materials & Methods
2.1 Chemicals
Potassium phosphate, potassium chloride and analytical grade ethanol for SEC buffer prepara-
tion were purchased from Merck (Darmstadt, Germany). Lysozyme was purchased from Sigma-
Aldrich (St. Louis, MO, USA). Methoxy-PEG aldehyde with an average molecular weight of
5 kDa was provided from NOF Cooperation (Tokyo, Japan). Sodium phosphate, sodium chloride
and sodium cyanoborohydride (NaCNBH3) for PEGylation buffer and IEC buffer preparation
were purchased from Merck (Darmstadt, Germany).
2.2 PEGylated lysozyme
2.2.1 PEGylation Reaction
Lysozyme (5 g/L) and PEG were dissolved in a 25 mM sodium phosphate buffer pH 7.2, con-
taining 20 mM sodium cyanoborohydride. The molar polymer to protein ratio was set to 6:1.
The reaction was carried out in a continuously shaken falcon tube at room temperature, for
10 h.
2.2.2 Preparative separation of lysozyme PEGamers
Single lysozyme PEGamers were purified using cation exchange chromatography. Toyopearl
GigaCap S-650M resin (Tosoh Biosience GmbH, Stuttgart, Germany) was packed in an Omnifit
glass column (25 mm x 400 mm, Diba Industries Ltd., Cambrigde, UK) according to the man-
ufacturer’s protocol. The resulting bed volume was 13.4 mL. A gradient elution was performed
at a flow rate of 0.7 mL/min with 25 mM sodium phosphate buffer pH 7.2 as mobile phase.
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After column equilibration, 50 mL sample mixture was loaded onto the column. Elution was
performed with a gradient from 0 to 200 mM sodium chloride over 21 column volumes. The
fractionation volume was set to 5 mL.
2.2.3 Molecular weight determination
Peak fractions resulting from the CEX separation were analyzed with respect to lysozyme
PEGamer sizes using combined size exclusion chromatography (SEC) and light scattering (LS).
This analysis was conducted using an A¨KTA Ettan system from GE Healthcare (Uppsala,
Sweden) in combination with a Dawn Heleos 8+ multi-angle light scattering detector and an
Optilap rEX refractive index (RI) detector, both from Wyatt Technology (Santa Barbara, USA).
For SEC a Superdex 200 GL10/300 (GE Healthcare, Uppsala, Sweden) with a mobile phase of
25 mM sodium phosphate, pH 7.0, containing 150 mM NaCl was used. The flow rate was set
to 0.8 mL/min. Injection volumes between 50 and 100µL were chosen. After UV absorbance
monitoring at 280 nm, each sample was measured by LS and RI detection. Molecular weight
(Mw) and hydrodynamic radius (Rh) calculation were calculated using the ASTRA software
(v.5.3.4.18).
2.3 Chromatography system setup
An UltiMate3000 RSLC x2 Dual system from Dionex (Sunnyvale, CA, USA) was used for
UHPLC analysis. The system was composed of two HPG-3400RS pumps, a WPS-3000TFC-
analytical autosampler and a DAD3000RS detector. The autosampler was equipped with a 5µL
sample loop. The volume of the injection needle was 15µL and the syringe size was 250µL.
For control of the UHPLC equipment and for data evaluation the Chromeleon software (6.80
SR10) was used. The software was extended by an additional time base. This enables a virtual
separation of the LC system in two parts which can then be controlled separately. Such a
setup is necessary in order to facilitate separate data recording of each analyzed sample when
performing SEC in interlaced mode. A thorough description of this setup and the performance
of interlaced chromatography has been described by Farnen et al. [9] and Diederich et al. [8].
2.4 Size exclusion chromatography
SEC columns (Zenix SEC-300) were purchased from Sepax Technologies (Newark, DE, USA).
The Zenix SEC-300 phase is a silica based material with a hydrophilic coating. The 3µm
sized particles have a nominal pore size of 300 A˚. Columns of the dimensions 4.6x150 mm and
4.6x300 mm were used. The short column was operated with a flow rate of 0.6 mL/min and
the long column with a flow rate of 0.4 mL/min. The columns were mounted with 0.2µm
Opti-Solv®EXPinlet filters (Optimize Technologies, Oregon City, OR, USA). For analysis,
5µl sample was injected via full loop injections and a 250 mM potassium phosphate buffer at
pH 6.8 with 200 mM potassium chloride was used as running buffer. To prevent fouling of the
columns due to PEG binding, 10 % (V/V) analytical grade ethanol was added to the buffer.
Interlaced injection mode was performed in order to eliminate lag time between injection and
elution of the first sample components.
2.5 Multivariate calibration
Where nothing else is stated, the multivariate regression models were calibrated with six chro-
matograms: single component chromatograms of each purified lysozyme PEGamer (mono-, di-,
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Figure 1: Chromatograms used
for calibration of the multivariate
regression models. One chroma-
toram of each pure component with
a concentration of 1 g/L with re-
spect to lysozyme and one chro-
matogram of a mixture of native
lysozyme and the three lysozyme
PEGamers, all with a concen-
tration of 0.5 g/L with respect
to lysozyme. ............................
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and triPEG) and native lysozyme, one chromatogram of all components in mass equivalent ratio
with respect to lysozyme, and one chromatogram of a blank injection. Chromatograms of the
pure components and the mixture of all four components are shown in Fig. 1A. The samples of
pure components all had a concentration of 1 g/L. In the mixed sample each component had a
concentration of 0.5 g/L. All mentioned concentration are with respect to lysozyme.
Different multivariate regression types were applied: multilinear regression (MLR), partial
least squares (PLS) regression, and multivariate curve resolution (MCR). All data processing
for multivariate calibration was performed with MATLAB. For multivariate regression with
MLR and PLS, the chromatographic data was preprocessed by mean centering. All PLS based
regressions were based on 4 latent variables. MCR was performed with the MCR-ALS algorithm.
After the MCR model was calibrated with the above mentioned six chromatograms, it was able
to deconvolute overlapping chromatograms unknown to the model. This resulted in values
corresponding to the integrated area of each pure component present in each of the validation
samples. From the initial MCR model calibration, the relation between area and concentration
was known and based hereon, the concentration of each component in each validation sample
was calculated. Hence, the MCR procedure is a combination of a multivariate approach for
chromatogram deconvolution combined with an univariate calibration of the determined area
and related concentration.
For multivariate calibrations based on integrated peak areas, calibration samples were gen-
erated according to a three layer onion design generated with MODDE (Umetrics, Sweden)
which consisted of 32 combinations of the four components.
2.5.1 Chromatographic data
The multivariate calibrations were based either on full chromatograms or four defined points
within the chromatogram. The four points were either defined as the UV signal at the elution
volume corresponding to the peak maximum of each pure component or as the UV signal
at actual peak maxima of the recorded chromatogram (see Fig. 2, left). For the purpose of
comparison, calibrations based on integrated peak areas were also performed. Here, vertical
peak limits as well as exponential rider skimming were applied to determine peak areas (see
Fig. 2, right). Data from full chromatograms consisted of the UV the signal recorded with a
frequency of 10 Hz for the short column and 5 Hz for the long column in a defined elution
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Figure 2: Schematic illustration of the different chromatographic data used for calibration. Left figure:
definition of peak maxima for calibration based on single chromatogram data points. Right figure:
definition of peak limits for calibration based on area integration.
range. This range was defined as 1.4 – 1.9 mL for the short column and 2.8 – 3.75 mL for the
long column with respect to chromatograms based on conventional injection mode as shown in
Fig. 3. A full chromatogram consisted of 712 data points when generated with the long column
and 500 data points when generated with the short column.
2.5.2 Determination of calibration precision
The calibrated concentration range for native lysozyme and each PEGamer was 0 – 1 g/L with
respect to lysozyme. To determine the precision of this suggested approach for evaluation of
chromatograms featuring low resolution, validation samples of defined concentrations were an-
alyzed. The validation samples were prepared according to a three layer onion design (designed
by MODDE) which resulted in 32 samples with seven different concentration levels (0, 0.25,
0.33, 0.5, 0.67, 0.75, and 1.0 g/L). From each sample three chromatographic runs were made
and before each injection of a new sample, a blank run was performed. This procedure was per-
formed using both the long and the short column. Based on the obtained chromatographic data,
the calibrated multivariate models were used to predict the content of each lysozyme PEGamer
and native lysozyme in the validation samples. For each model and each component the 95 %
confidence intervals were calculated based on the total of 96 analyzed samples (threefold injec-
tions of 32 validation samples). First the MATLAB ‘poly1’ fit function was used to fit a linear
function to the relation between the concentration predicted by the multivariate model and
the nominal concentraion in the validation samples. After the fitting procedure, MATLAB was
programmed to return the upper and lower confidence bounds for each linear fit. Finally, the
confidence interval for each calibration and component was calculated by adding the upper and
lower confidence bound. It should be noticed that the confidence interval does not to give excact
information on the precision for different concentration levels within the calibration. Hence, the
confidence intervals were only used for comparison of the different calibrations. To obtain more
detailed information on presicion, the relative standard devaition (RSD%) was calculated for
each concentration interval and presented for a selection of the most precise calibrations.
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2.5.3 Dynamic and static calibration
Two modes of multivariate calibration were used. The simplest was a static mode where one
set of calibration sample chromatograms recorded immediately before analysis of the validation
samples was used for calibration. However, to be able to account for systematic changes in col-
umn performance over time, a dynamic approach was developed. In order to do so, calibration
sample chromatograms were recorded both before and after the analysis of the validation sam-
ples. The regression model was then recalibrated for each validation sample based on a linear
interpolation between the chromatograms recorded before and after analysis of the validation
samples. The interpolations were calculated using Eq. 1:
vi,j =
n− j
n
· vi,pre + j
n
· vi,post (1)
where vi is a vector containing the recorded chromatogram of calibration sample i, n is the
total number of measured samples, and j is the number of the sample in the sample sequence
for which the model is recalibrated. The indices pre and post indicates whether a calibration
sample was measured before or after the validation samples.
3 Results & Discussion
The aim was to establish a fast SEC assay (∼ two minutes) for the quantification of lysozyme
PEGamers and native lysozyme. Hence, a type of SEC columns which allows the use of rather
high flow rates up to 3 cm/min was applied. In order to eliminate the lag time inherent in SEC
analysis, injections were performed in interlaced mode. Finally, the narrow diameter of the
chosen column type allowed for a sample size of 5µL which minimizes the time necessary for
sample injection preparation by the autosampler. All these measures resulted in an assay time of
five and two minutes for the long and the short column, respectively. These measures, however,
also caused insufficient resolution for precise quantification of all the lysozyme PEGamers when
based on determined peak areas. Therefore, multivariate calibration was applied to achieve
accurate and precise quantification despite the low resolution.
3.1 Assay time and chromatographic resolution
The resulting separation of lysozyme PEGamers using two different column lengths (150 and
300 mm) is shown in Fig. 3. The presented chromatograms result from samples injected in
traditional sequential mode and, as can be seen, less than 50 % of the recorded signal contains
relevant information. Hence, interlaced injection mode was applied to reduce the analysis time
significantly without decreasing the resolution further. The final assay for the long column was
performed with an elution volume of 2.0 mL per injected sample at a flowrate of 0.4 mL/min.
This resulted in an assay time of five minutes. The final assay for the short column was
performed with an elution volume of 1.2 mL per injected sample at a flowrate of 0.6 mL/min.
This resulted in an assay time of two minutes.
column Chromatographic resolution of lysozyme PEGamers:
length native/mono-PEG mono-/di-PEG di-/tri-PEG
300 mm 2.72 1.47 0.79
150 mm 1.66 0.98 0.35
Table I: Chromatographic resolu-
tion listed for each column length.
Each resolution was determined by
injecting equal amounts of the two
components in question.
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Figure 3: Separation of native lysozyme, mono-, di- and, tri-PEGylated lysozyme with two columns of
different lengths. The samples injected on the two columns were identical and contained equal amounts
of each component with respect to lysozyme. Left: separation performed on a 150 mm column. Right:
separation performed on a 300 mm column.
The determined chromatographic resolutions generated by both columns of lysozyme PEGamers
and native lysozyme are listed in table I. These results are based on injection of equal amounts
of the two components in question. A resolution of R & 1.5 is in general sufficient for correct
quantification based on integration of peak areas. The short column only generated sufficient
resolution for native and mono-PEGylated lysozyme whereas the long column generated suffi-
cient resolution for all components except the tri-PEGylated lysozyme. These results accentuate
the challenging task of separating higher PEGylation forms using SEC to a degree sufficient for
quantification based on area integration. If sufficient resolution is to be achieved for the higher
PEGylation forms, a great amount of dispensable resolution will be generated for native and
lower PEGylation forms. Therefore, in order to save time, multivariate calibration was applied
in the attempt to achieve precise and accurate quantification despite low resolution.
3.2 Calibration precision
Multivariate models were calibrated based on multilinear regression (MLR), partial least squares
(PLS) regression, and multivariate curve resolution (MCR). Further, traditional quantification
based on univariate calibration of determined peak areas was performed in order to compare
multivariate calibration with the traditional approach. Finally, MLR calibration based on peak
areas and peak heights was applied to investigate whether low peak resolution could be com-
pensated by multivariate calibration of these parameters.
Confidence intervals were used to compare the precision of the different calibration ap-
proaches, both with regard to regression type and the data used for calibration (i.e. full chro-
matograms, peak maxima, peak areas). For this purpose, the mean confidence interval of the
two components with the lowest chromatographic resolution was determined, in this case the
di- and tri-PEGamers. The results are listed in table II and are presented and discussed in the
following sections.
3.2.1 Static calibration
In general, a clear increase in precision was achieved by applying static multivariate calibration
of chromatographic data. For the long column, the precision increased from 0.0476 g/L to
0.0155 g/L by applying MLR to full chromatogram data instead of univariate calibration of
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regression model data confidence
type mode range interval
300 mm column
MLR static full chromatogram 0.0155
MLR static peak maxima 1 0.0164
MCR static full chromatogram 0.0167
PLS static full chromatogram 0.0186
MLR static peak maxima 2 0.0206
MLR static peak area 3 0.0394
Univ. static peak area 3 0.0476
Univ. static peak area 4 0.0768
150 mm column
MLR static peak maxima 1 0.0226
MCR static full chromatogram 0.0226
MLR static full chromatogram 0.0247
PLS static full chromatogram 0.0347
MLR static peak area 3 0.0453
MLR static peak maxima 2 0.0491
Univ. static peak area 3 0.0580
MLR dynamic peak maxima 1 0.0164
MLR dynamic full chromatogram 0.0167
MCR dynamic full chromatogram 0.0173
PLS dynamic full chromatogram 0.0191
1) signal height to base line at retention volumes corresponding
to peak maxima of pure components
2) signal height to baseline at peak maximum
3) vertical peak limits
4) exponential rider skimming
Table II: Calibration results
presented in order of precision.
Different regression types were
used to calibrate multivariate
models based on different chro-
matogram data for evaluation of
analytical chromatograms. The
resulting confidence intervals are
listed for each of the differ-
ent regression types along with
model mode and the applied chro-
matogram data. Further, re-
sults based on traditional area in-
tegration and univariate calibra-
tion are listed. See Fig. 2 for
a schematic illustration of the
different applied chromatogram
data.
peak areas. Based on equivalent calibration for the short column, an increase in precision from
0.0580 g/L to 0.0247 g/L was achieved. For the stronger overlapping peaks generated by the
short column, MLR calibration based on only four points in the chromatogram (obtained at
VR of the pure components) resulted in a more precise calibration with a confidence interval
of 0.0226 g/L. MLR gave more precise results than PLS and MCR both for the long and the
short column. Further, MLR calibration based on peak areas was more precise than univariate
calibration of peak areas, however much less precise than calibration based on full chromatogram
data. MLR calibration based on peak heights at peak maxima was more precise than MLR
calibrations based on peak areas for the long column, however the opposite was the result for
the short column. The elution profiles of the pure components (see Fig. 4) shows that severe
peak overlapping was limited to approximately 50 % for the long column. Therefore the position
of peak maxima was less influenced by the presence of other components when comparing the
long column with the short column.
3.2.2 Dynamic calibration
The precision of the univariate peak area based calibration decreased by ∼ 25 % when compar-
ing the results obtained by the long column to those obtained by the short column. In com-
parison, the precision of the multivariate calibration based on MLR and full chromatograms
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Figure 4: Overlay of single component chromatograms before and after 140 sample injections. Left:
300 mm column. Right: 150 mm column.
decreased by ∼ 70 %. Even though the absolute value of the determined confidence interval
was still several times lower for the multivariate calibration compared to univariate calibration
(0.0247 vs. 0.0580 g/L) when using the short column, the relatively high decrease in precision
of the multivariate calibration when switching from the longer to the shorter column (e.g.
0.0155 vs. 0.0247 g/L) was not expected. In Fig. 4 - left an overlay of pure component chro-
matograms recorded before and after 140 sample injections on the long column is shown. The
data shows stable column performance without a systematic change in peak height or retention
volume over time. Fig. 4 - right displays the equivalent data for the short column and here a shift
in retention time for all components along with peak broadening can be observed. To overcome
the inaccuracy caused by the change in column performance, a dynamic calibration approach
was used. This calibration was based on linear interpolation of calibration chromatograms
recorded immediately before and after the analysis of the validation samples. It was chosen
to apply linear interpolation as the observed change in retention time was linear. The use of
dynamic calibration for the short column resulted in an assay of similar precision compared to
the static calibration of the long column (0.0167 vs. 0.0155 g/L – MLR, full chromatogram).
In Fig. 5 the chromatogram residuals of the validation sample chromatograms are displayed.
The shown residuals are derived from both the dynamic and the static PLS calibration for the
short column based on the full chromatograms. The variation of the chromatogram residuals
remains constant over the period of analysis for the dynamic calibration, where as the variation
increases throughout the period of analysis for the static calibration. This supports the decision
to use linear interpolation for the dynamic calibration.
In order to visualize the effect of dynamic calibration, three artificial chromatograms were
created and displayed along with a true chromatogram of a validation sample (Fig. 6). The
artificial chromatograms were created by a linear combination of pure sample chromatograms
in a ratio corresponding to the true chromatogram. Two of the artificial chromatograms were
based on the calibration chromatograms recorded either before or after the analysis of the
validation samples. Neither of these chromatograms were of good resemblance to the validation
sample chromatogram. The third artificial chromatogram was based on the linear interpolated
chromatograms of the calibration samples which were created for the dynamic calibrations. This
chromatogram was built to match the point in time where the displayed true chromatogram was
recorded and exhibited a high resemblance to the true validation sample chromatogram. For
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Figure 6: Visual comparison of the ef-
fect of dynamic calibration. One true chro-
matogram and three artificial chromatogram
based on linear combinations of pure com-
ponent chromatograms are displayed. Two
of the artificial chromatograms were built
from the pure component chromatograms
recorded either before (artificial 1 ) or after
(artificial 2 ) analysis of the validation sam-
ples. The third artificial chromatogram (ar-
tificial D) was built from the linear interpola-
tions used in the dynamic calibrations. The
linear interpolation was built to correspond
to the point in time where the true samples
was analyzed.
the right peak (monoPEG-protein conjugate), the resemblance was high both for peak intensity
and peak shift. The fact that the left peak of the sample chromatogram deviated from the
dynamic calibration chromatogram in peak intensity is most likely due to a pipetting error
during preparation of the validation samples.
3.2.3 Concentration related precision and sensitivity
The concentration related precision was determined for the dynamic and static MLR calibra-
tions based on the short column and the MLR calibration based on the long column. The
relative standard deviation (RSD%) for each contration is displayed in Fig. 7. The displayed
RSD% values are mean values of the RSD% for di- and tri-PEGylated lysozyme. For all three
calibrations, the precision increased from the first to the second concentration level (0.25 g/L
– 0.33 g/L). For all concentration levels, the precision of the static MLR calibration based on
the 150 mm column was lowest (RSD∼ 3 – 1.5 %). The precision for all concentration levels
was similar for the dynamic MLR calibration based on the 150 mm column and the static MLR
calibration based on the 300 mm column. This is in accordance with the finding that the overall
precision of these calibrations were similar (95 % confidence interval: 0.0167 g/L and 0.0155 g/L
- see table II). This means that both the overall precision and the specific precicion achieved
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Figure 7: RSD % values for the
concentration levels included in the
validation sample design. Displayed
are mean values of the determined
RDS % for di- and tri-PEGylated
lysozyme. The value dispayed for
the concentration zero (grey bar) are
LOQ values. Also the LOQ values
are mean values of the determined
LOQ for di- and tri-PEGylated
lysozyme. ............................
...................................
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for the long column can be maintained for the short column by applying multivariate calibra-
tion. For further comparison and characterisation of the calibrations, the limit of quantification
(LOQ) was determined. LOQ was determined as six times the standard deviation of all ‘zero’
predictions in the calibration samples for each component. Again, the displayed LOQ values
are mean values of the determined LOQ value for di- and tri-PEGylated lysozyme. With regard
to the LOQ value, the dynamic approach does increase the sensitivity of the method, however
not to the level of the MLR calbration based on the 300 mm column.
4 Conclusion and Outlook
The aim of establishing an SEC assay for the quantification of lysozyme PEGamers with an
analysis time of two minutes was achieved. The presented work clearly demonstrates that by ap-
plying multivariate calibration for the quantitative evaluation of low resolution chromatograms
the precision can be enhanced significantly when compared to traditional univariate calibration.
Hence, fast chromatographic assays can easily be achieved by applying short columns and fast
flow rates. The tested chromatographic assays included resolutions down to 0.35 demonstrating
how little resolution is actually sufficient to achieve a highly precise chromatographic assay. The
lower limit of resolution necessary for precise calibration is still to be determined. Further, the
results demonstrated that a change in column performance over time can be handled without
difficulty by using a dynamic calibration approach.
In the presented work, pure samples were used for calibration. If pure material is at hand
or easily achievable, this is the most straightforward approach. If pure samples are difficult or
impossible to obtain, mixed samples of defined composition can also be used. This then requires
an alternative assay or analytics to define the mixed samples and further these samples must
contain sufficient variation.
The use of multivariate calibration is of course not limited to SEC. Any robust chromato-
graphic assay established for defined samples can be evaluated by the presented approach. The
approach cannot be applied to complex samples in which unknown peaks occur in the area
used for calibration and also chromatographic assays based on non-linear chromatography will
demand more sophisticated multivariate calibration of non-linear nature. This might increase
the calibration complexity to a level which is no longer leveraged by the gained increase in assay
speed. However, this is still to be investigated.
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In working environments with limited time for assay development and data evaluation, it
might be an unmanageable task to perform data evaluation not inherent in the chromatography
system software. Hence, we propose the integration of multivariate calibration directly in the
commercial software supplied with the chromatography systems.
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Abstract
The application of high throughput experimentation (HTE) in protein purification process devel-
opment has created an analytical bottleneck. Using a new label-free and non-invasive method-
ology for analyzing multicomponent protein mixtures by means of spectral measurements, we
show that the analytical throughput for selective protein quantification can be increased sig-
nificantly. An analytical assay based on this new methodology was shown to generate very
precise results. Further, the assay was successfully applied as analytics for a resin screening
performed in HTE mode. The increase in analytical throughput was obtained without de-
creasing the level of information when compared to analytical chromatography. This proves
its potential as a valuable analytical tool in conjugation with high throughput process devel-
opment (HTPD). Further, fast selective protein quantification can enhance process control in
a commercial production environment and, hence, minimize the need for off-line release analysis.
Keywords: protein analytics, specific protein quantification, label-free, non-
invasive, partial least squares, high throughput process development
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1 Introduction
Over the past few years, the use of high throughput techniques for development of protein purifi-
cation processes has increased strongly. The main drivers of this shift towards high throughput
process development (HTPD) have been (and still are) the need to speed up both time to clinic
and time to market. Automated performance of unit operations in a miniaturized and parallel
mode has delivered the high experimental throughput which is the basis of HTPD. The automa-
tion has been realized using robotic workstations with liquid handling systems where sampling
is commonly performed in microtiter plates.
Alongside the development of high throughput experimentation (HTE) techniques, a trend
of replacing the traditional ‘one factor at the time’ screenings with more sophisticated ap-
proaches such as factorial designs, intelligent search algorithms, and mechanistic modeling has
evolved [1–3]. These approaches make process development more efficient and can result in
a deeper understanding of the developed processes. However, regardless of how sophisticated
a search algorithm or design is used to improve the experiment to information ratio, a high
number of samples have to be analyzed when performing state of the art HTPD. In order not
to compromise the throughput and level of automation, univariate spectroscopic measurements
performed in plate readers is the most comfortable analytical solution. If the nature of the
experiments is more complex and requires selective or specific protein quantification, analyti-
cal chromatography, mass spectrometry, electrophoresis and/or enzyme linked immunosorption
assay can be applied. However, all methods have drawbacks related to throughput, sample
preparation, and/or automated integration. Hence, the enhanced experimental throughput of-
ten creates an analytical bottleneck where the experimenter is forced to make decisions on the
basis of a trade off between analysis time and analytical information.
Liquid chromatography is the main workhorse of modern protein purification. Accordingly,
liquid chromatography, in batch as well as column mode, is among the unit operations readily
established and applied in HTPD [4–6]. Batch experiments can give information on selectivity,
uptake kinetics and static binding capacities in studies of different phase combinations. From
column experiments, information on dynamic binding capacities and chromatographic resolution
can be derived. Both batch and column chromatography in HTE mode can also be used to
determine parameters for mechanistic modeling of chromatographic processes [7].
Column chromatography in HTE mode generates hundreds of samples per hour and hence
represents a major analytical challenge if the high experimental throughput is to be main-
tained. The objective of the work presented here, was to develop and establish an assay which
would limit the analytical trade off without compromising the throughput of the experimental
performance. Such an assay would in general be useful to unit operations relevant to protein
purification where selective protein quantification is necessary: e.g. membrane chromatogra-
phy, batch chromatography, selective protein precipitation, protein crystallization and aqueous
two-phase systems.
The standard univariate spectroscopic assay used to quantify proteins in aqueous solutions
is based on the application of the Lambert-Beer law to a measured UV absorption caused by
solute protein molecules. In most cases, the absorption ascribable to the aromatic structures in
the residues tryptophan, tyrosine, and phenylalanine is used. Of these amino acids, tryptophan
and tyrosine have far the strongest absorption. Fig. 1 displays the absorption spectra in the
range from 220 nm to 300 nm of pure tryptophan, tyrosine, and phenylalanine in aqueous
solutions. Their spectra are characterized by two maxima in the mid-UV range: the most
intense around 230 nm and one of lower intensity and more wide stretching around 280 nm.
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Figure 1: Mid-UV absorp-
tion spectra of tyrosine, trypto-
phan, and phenylalanine. The
concentration of tyrosine and
tryptophan was 0.1 g/L. Due
to the relative low absorptiv-
ity of phenylalanine, absorption
spectra of both the concentra-
tions 1.0 g/L and 0.1 g/L are
displayed. ............................
...................................
The absorptivity of phenylalanine is approximately one magnitude lower and both maxima are
shifted 20 nm towards lower wavelengths. Due to material and apparatus issues, it is often
preferred to measure the absorption at 280 nm. However, as the extinction coefficient (ǫ) differs
depending on the amount and kind of aromatic residues present in a protein, the method is
only applicable to pure protein solutions. For absolute quantification of proteins with unknown
extinction coefficients or protein mixtures, methods combining the absorption at 280 with the
absorption at 205 nm where also the peptide bonds absorb can be found in the literature [8, 9].
Mid-UV spectral data have been applied for identification and selective quantification of
many different compounds other than proteins: e.g. [10–12]. However, until now mid-UV ab-
sorption spectra of proteins have mainly been applied to monitor structural and binding aspects
of proteins: e.g. [13–15]. One exception is the application of UV absorption spectra to deter-
mine protein and nucleic acid content of viruses [16]. As can be seen in Fig. 1, the absorption
spectra of the aromatic amino acids differs significantly, not only in intensity but also in shape.
This fact will cause the absorption spectra of different proteins to change depending on the
ratios of the aromatic residues present in the proteins. Awareness of this fact combined with
the spreading application of chemometric approaches (e.g. multivariate calibration) in biomed-
ical analysis [17] has been the inspiration to a new methodology for analyzing multi-component
protein mixtures in a label-free and non-invasive mode. According to the definition by Lavine
[18], chemometrics is an approach to analytical and measurement science that uses mathemati-
cal, statistical, and other methods of logical science to determine properties of substances that
would otherwise be difficult to determine directly. In this case the substance property is the
selective protein concentration in a mixture of several proteins and the applied ‘logical science’
is partial least squares - projection to latent structures (PLS) regression. This was chosen as
PLS is known to be particular good in coping with expected collinearity of the spectral data
[19].
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2 Materials & Methods
2.1 Disposables
Sample preparation: 96 well square deep well plates (DWP), volumetric capacity 2 ml,
polypropylene (VWR, Germany). Mid-UV spectra measurement: 96 well half area UV
microtiter plates (MTP), volumetric capacity 180 µL, polystyrene, flat bottom and 384 square
well MTP, volumetric capacity 110 µL, polystyrene, flat bottom (Greiner, Germany). Chro-
matography: RoboColumns purchased prepacked with 200 µL of the following resins: CM
Ceramic HyperD F, Toyopearl SP 650 M, SP Sepharose FF, and Fractogel EMD SO3 (Atoll,
Germany).
2.2 Model Proteins
The following model proteins were used: lysozyme (lys) from hen egg white, cytochrome C
(cytC) from horse heart and ribonuclease A (ribA) from bovine pancreas (Sigma-Aldrich, Ger-
many). These proteins compose a convenient model system for method development of protein
purification due to the distribution of their isoelectric points. At neutral pH, separation can be
achieved using cation exchange chromatography.
2.3 Liquid Handling Station
The generation of protein samples for model calibration, model validation, and elution buffers
as well as the chromatographic experiments were performed automated on a Tecan Freedom
Evo 200 (Tecan, Germany) liquid handling station (LHS). To enable performance of column
chromatography on the LHS, a custom made column carrier was used. A similar carrier is
available under the name Te-Chrom (Tecan, Germany). A thorough description of parallelized
chromatography performed automated on a LHS has been published by [6] and [7]. Further, the
LHS was equipped with an Infinite 200 plate reader (Tecan, Germany) to measure the mid-UV
spectra of the calibration and validation samples as well as the chromatographic fractions. The
liquid handling station was operated with EVOware 2.0. Import of values for pipetting volumes
and export of spectral data was handled via Excel (Microsoft, Redmond, USA).
2.4 Experimental Setup
2.4.1 Model Calibration and Model Validation
The calibration and validation samples were based on a four level D-optimal onion design gener-
ated with MODDE (Umetrics, Sweden). In total, the four level onion design with three center
points consisted of 29 samples. The design covered 19 mixing ratios and nine concentration
levels from 0-0.7 g/L. In fig. 2A the mixing ratios of all three proteins and the absolute concen-
trations of ribA and cytC are displayed. An additional concentration level at 0.05 g/L was added
to the four layer onion design, however only as pure samples. In total a sample set consisted
of 32 samples. Two mL of each sample were prepared from stock solutions, containing 2.1 g/L
protein in a sodium phosphate buffer at pH 7. Preparing 2 mL of each sample, enabled testing
of different plate types and sample volumes based on the same sample stock. For the mea-
surement of the absorption spectra, a defined volume of the prepared samples were transferred
to UV transparent MTPs. The absorption spectra were measured with 1 nm resolution in the
range 240-300 nm. For model calibration based on the obtained spectral data, the MATLAB
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based PLS toolbox (EigenVector, USA) was used. The spectral data was preprocessed by mean
centering which is done by subtracting the mean spectrum of all calibration samples from each
protein spectrum. Method validation was performed according to the flow scheme displayed in
fig. 2. The setup was designed to obtain a reliable measure of the possible obtainable precision
taking into account pipetting errors, measurement error, and errors caused by plate deviations.
The setup consisted of six independently pipetted sample sets (fig. 2C,E). Five sample sets were
used to calibrate five models (fig. 2D). All five calibrated models were then used to experimen-
tally determine the concentrations of the sixth sample set (fig. 2E). From these values, absolute
errors, relative errors, and 95 % confidence intervals were calculated (fig. 2F-H).
2.4.2 Resin Screening
All columns were equilibrated with 5 CV (1 CV = 200 µL) loading buffer (20 mM sodium
phosphate, pH = 7) before loading them with 0.25 mg of each protein per column. This protein
load equals 3.75 g/L resin of total protein. Before starting the actual column experiments, 24
different buffer solutions with increasing salt concentrations were prepared and stored in DWPs
until use. The prepared buffer solutions composed a linear step gradient from 0-500 mM NaCl
and was used to elute the proteins in 24 CV. Each gradient step was collected as one fraction.
After completed elution, 100 µL of each elution fraction were transferred into UV grade MTPs
and the absorption spectra were measured. Based on these spectra, the protein content in the
samples was determined.
2.4.3 Peak Fitting and Calculation of Chromatographic Resolution
To evaluate the chromatographic separations, an asymmetric Gaussian function was fitted to
the data points. The fitting was performed using the graphing and data analyzing software Orig-
inPro8.5 (OriginLab Corporation, USA) which has an asymmetric Gaussian fit function under
the name bigauss. The bigauss fitfunction is a two-step function which separately describes the
leading and the trailing edges of an asymmetric peak using two different gauss curves. The
bigauss fitfunction returns the values w1 (FWHM/2 - left side fit) , w2 (FWHM/2 - right side
fit), xc (retention at peak maximum), H (maximal peak height), and y0 (base line) for each
peak. Based on the parameters w1, w2, and xc the resolution of two adjacent peaks p1 and p2
was calculated according to:
Rp1,p2 =
2.345(xc,p2 − xcc,p1)
4(w2,p1 + w1,p2)
(1)
The above described equation is a derivative of the standard equation for chromatographic
resolution based on peak basis width at 4σ (wb) and the distance between peak maxima (tR2-
tR1):
Rs =
2(tR2 − tR1)
wb1 + wb2
(2)
2.4.4 Analytical Chromatography
For comparison, the protein concentrations in the samples generated in the resin screening were
quantified using a Mono S 4.6/100 PE column (GE Healthcare, Germany). The column was
loaded with 20 µL sample and eluted with a multi linear sodium chloride gradient. Buffer A:
20 mM sodium phosphate, pH 7, buffer B: 20 mM sodium phosphate, 500 mM sodium chloride,
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Figure 2: Design of the model calibration and validation samples followed by a flowchart describing
the validation procedure. A: Mixing ratios of all three proteins and absolute concentrations of cytC and
ribA. B: Protein stock solutions C: Five identical sample sets prepared individually from the protein
stock solutions. D: Five calibrated models based on the five sample sets. E: Sixth sample set of which
the concentrations were experimentally determined using the five calibrated models. F: Absolute errors
of the experimentally determined concentrations displayed as a function of the nominal concentration.
G: Relative error of each experimentally determined protein concentration as a function of the nominal
concentration. H: Experimentally determined protein concentration plotted as a function of the nominal
concentration. The red lines display 95 % confidence interval for each protein species calculated on basis
of the experimentally determined values.
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pH 7. Gradient: buffer B 0-20 % from 0-8 min, buffer B 20 % from 8-12 min, buffer B 20-40 %
from 12-18 min, buffer B 100 % from 18-20 min, buffer B 0 % from 20-25 min. The flow rate
was 1 mL/min.
3 Results & Discussion
In the presented work, we describe a fast and automated assay for selective protein quantifi-
cation. The label-free and non-invasive methodology on which the assay is based, uses PLS
to correlate absorption spectra to selective protein concentrations. The developed assay has
been subjected to a thorough validation and the results hereof will be presented and discussed.
Further, an application relevant to HTPD is presented and the results are compared to results
generated using standard analytical chromatography.
3.1 Protein Mid-UV Absorption Spectra
In general, proteins absorb UV light in the mid-UV range. This absorption is mainly caused by
the chromophoric properties of the three aromatic residues; tryptophan, tyrosine, and pheny-
lalanine. Further, some proteins exhibit additional absorption in the visible range due to other
chromophoric properties; e.g. green fluorescence protein (λmax ∼ 488 nm) and cytochrome C
(λmax ∼ 526 nm). Present in a mixture, these proteins can easily be quantified separately by
measuring the absorption at wave lengths specific for each protein. In contrast, specific quantifi-
cation of proteins with absorption characteristics only ascribable to their aromatic residues and
peptide bonds, can not be performed by such a straight forward method. However, the ratio
and number of aromatic residues will vary among different proteins, and therefore the intensity
and shape of the related UV absorption spectrum will vary.
Fig. 3A displays the absorption spectra of the three model proteins ribA, cytC and lys in the
range 240-300 nm at a concentration of 0.5 g/L. To depicture the extend to which the spectral
shapes vary independently of spectral intensity, difference spectra based on normalized spectra
were calculated (Fig. 3B). The normalization was based on the maximal absorption value in
the range 270-290 nm which was set to 1.0 AU. Fig. 3C displays the difference spectra build by
subtracting the mean of all three normalized spectra from each individual normalized spectrum.
Lys and ribA have similar spectral shapes in the range 250-280 nm and deviates in the ranges
240-250 nm and 280-300 nm. The spectrum of cytC is different from both other spectra with
the exception of the lys spectrum in the range 280-290 nm.
3.2 Method Validation
A multivariate calibration model links a relation between several input variables to one or more
properties of interest. In this case the input variables are the spectral data and the properties
of interest are the selective concentrations of the different proteins contained in a sample. To
determine the possible precision which can be obtained for the correlation of spectral data
and protein concentrations using PLS, a thorough validation was undertaken according to the
scheme presented in fig. 2. As a measure for precision, the 95 % confidence interval was used.
The confidence interval was based on the five fold experimental determination of the protein
concentrations in the samples of sample set 6 (see fig. 2).
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In the following the validation results are presented. This includes the influence of plate type
and sample volume, which in MTPs determines the optical path length, method robustness re-
garding salt concentration and temperature, in silico parameters such as choice of preprocessing
and number of latent variables used for calibration, and finally PLS was compared to multiple
linear regression (MLR).
3.2.1 Number of Latent Variables
PLS calibration is based on a data reduction with the objective to capture only the significant
variation needed for calibration. Initially, it was tested how the level of reduction would influence
precision of the resulting PLS model. Here, the level of reduction is expressed by the number
of latent variables included in the calibration of the PLS model where a low number of latent
variables corresponds to a high data reduction. For each tested number of latent variables and
for each protein species, the 95 % confidence interval was calculated. Further, the confidence
intervals for all three proteins were summarized for each number of latent variables to give a
measure for the overall precision of the model. In fig. 4A the confidence intervals are displayed
as a function of the number of latent variables in the tested range from 3-11. The curves
fitted to the data points serves the visualization. Whereas cytC describes a low but continuous
increase over the tested range, both lys and ribA exhibit a minimum at six latent variables.
This is consistent with the fact that cytC differs the most from the mean spectrum of all three
proteins (see fig. 3). Hence, the most significant variation in the data is correlated to the
cytC concentration and this variation will then be described more accurately by the first latent
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variables compared to ribA and lys. The sum of the confidence intervals is lowest for six latent
variables. However, using six latent variables is a compromise, as the precision of cytC is not
optimal at this point. Alternatively, a separately calibrated model for cytC could be used. Due
to the very small difference in precision, it was chosen to base further method validation on
models calibrated for all proteins based on six latent variables.
3.2.2 Plate Type and Sample Volume
The influence of plate type and sample volume was tested by comparing the resulting confidence
intervals. Included were two MTP types: 384 well MTP (square wells) and 96 well MTP (half
area wells). In the 384 well MTP the tested volumes were 40, 60, and 80 µL corresponding to
path lengths of 3.3, 5.5, and 6.7 mm. In the 96 well MTP the tested volumes were 40, 75, 100,
and 150 µL corresponding to path lengths of 2.6, 4.7, 6.2, and 9.0 mm. The influence of sample
volume and plate type is displayed in fig. 4B. To simplify the visualization, only mean values
and standard deviations of the confidence intervals of all three proteins are displayed. In the
range 2.6-5.0 mm, the optical path length correlated with a linear decrease of the confidence
interval, independently of plate type. Above 5.0 mm the confidence interval decreased further
when using the 96 well MTP, however the variance (expressed by the standard deviation) of
the confidence intervals increased for the highest measured path length of 9.0 mm. Hence, it
was chosen to perform all other experiments with 100 µL sample in a 96 well MTP where the
variance of the single confidence intervals was low (ribA: 0.031 g/L, cytC: 0.032 g/L, lys: 0.028
g/L) and the mean value was not significantly higher compared to what was achieved with 150
µL (0.031 vs. 0.027 g/L).
3.2.3 Protein Concentration Range
The precision over the calibrated concentration range is displayed in fig. 4C (100 µL samples
measured in 96 well MPTs and PLS models calibrated with 6 latent variables). The curves
fitted to the data points serve to visualize the observed trends. They do not include the lowest
concentration of 0.05 g/L, as this concentration level was only included in the form of pure
samples and therefore not representative for complex samples. The precision increased with
increasing protein concentrations up to 0.525 g/L, which is expressed by the decreasing relative
standard deviation. For ribA and cytC the relative standard deviation decreased from 7 % at
0.05 g/L to 1 % at 0.525 g/L. Over the same range, the relative standard deviation for lys
decreased from 3 % to 1 %. Above a concentration of 0.525 g/L, the relative standard deviation
for all three protein species increased. The descending order of precision within the protein
species (lys>ribA>cytC) correlated with the previously determined confidence intervals based
on the same data (lys: 0.028 g/L, ribA: 0.031 g/L, cytC: 0.032 g/L). The initial decrease of
the relative standard deviation is explained by pipetting errors and measurement noise having
the highest impact at low concentrations. The increase of the relative standard deviation above
0.525 g/L is also expectable, since only a very low amount of light passes the sample at high
protein concentrations. The lower limits of quantification (determined as 6σ) were 0.04, 0.06,
and 0.03 g/L for ribA, cytC, and lys, respectively. This is not immediately consistent with the
relative standard deviations at the lowest concentration level presented in fig. 4C. However, as
already mentioned, the concentration level at 0.05 g/L was only included in the form of pure
protein samples is therefore not representative for complex samples.
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3.2.4 Calibration and Preprocessing
MLR is a classical method for multivariate calibration. MLR is known to be sensitive to
collinearity which is inherent in spectral data, as these do not consist of independent variables.
To assert that PLS actually generates more precisely calibrated models, both approaches were
tested based on identical data. The measurements were performed in 96 well MTP with 100 µL
sample and PLS models were based on six latent variables. Further, it was tested whether mean
centering of the spectral data has a positive effect on the calibration. For comparison, the re-
sulting 95 % confidence intervals were used (listed in table 1). The MLR model calibrated with
mean centered data was shown to have a precision approximately three times lower compared
to a PLS model calibrated with mean centered data. Further, mean centering of the spectral
data showed to be essential in obtaining a precise model, as the confidence intervals increased
by one order of magnitude when the models were calibrated based on raw data compared with
the achieved precision of models calibrated based on mean centered data. Hence, the best result
was achieved using mean centered data in combination with PLS.
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calibration applied confidence interval (g/L)
method preprocessing ribA cytC lys
PLS mean centering 0.031 0.032 0.028
PLS none 0.227 0.349 0.275
MLR mean centering 0.097 0.089 0.102
MLR none 0.350 0.590 0.414
Table I: confidence intervals for each
protein species based on models cali-
brated with PLS or MLR. Each model
type was based on raw or mean cen-
tered data.
3.2.5 Method Robustness
All factors influencing the absorption in the applied range from 240-300 nm will have an effect
on precision and accuracy of the method. Hence, it was tested whether the addition of sodium
chloride has an effect on precision and accuracy of the calibration. In the tested range from 0-250
mM sodium chloride a significant change in precision or accuracy was not observed. Further,
it was tested whether changing temperature of the sample has an influence. The tested range
was 23− 35 ◦C. In a sample containing equal amounts of all three proteins, the determined lys
concentration exhibited a decreasing tendency and the determined ribA and cytC concentrations
exhibited a increasing tendency, both with increasing temperature. However, the change was
not significant.
3.3 Application for Process Development
The applicability of the established analytical assay for selective protein quantification was
tested on an adsorber screening performed in HTE mode. The screening including four differ-
ent cation exchanger resins (CM Ceramic HyperD F, Toyopearl SP 650 M, SP Sepharose FF, and
Fractogel EMD SO3) and generated a total of 96 samples. The objective of the screening was to
determine which adsorber would yield the best separation of ribA, cytC, and lysozyme. After
determining the protein concentrations in the fractions, an asymmetric Gaussian function was
fitted to the data points. In fig. 5A the resulting chromatograms are displayed. Mass balances
and chromatographic resolutions were calculated based on the fitted curves. For comparison, the
protein concentrations in the fractions were also determined using analytical chromatography.
Based on both analytical approaches, the chromatographic resolutions and the mass balances
were calculated. The results hereof are displayed in fig. 5B-C. A tendency of marginally higher
resolutions was observed when using analytical chromatography for protein quantification. This
can be explained by the higher precision of the analytical chromatographic assay at low concen-
trations (RSD ∼ 1 % at 0.05-0.3 g/L). RibA and cytC were separated with similar resolution
(R ∼ 2) on column 1 and 2. CytC and lys were separated with similar resolution (R ∼ 2.5)
on column 2 and 4. Only column 2 was able to separate all three proteins and column 3 was
not able to separate any of three proteins under the applied conditions. Despite the mentioned
differences in the determined resolutions, both analytical approaches delivered the same overall
result of resin 2 (Toyopearl SP 650 M) being the best suited and resin 3 (CM Ceramic HyperD
F) being the least suited resin for the separation of the three proteins. The mass balances for
each of the protein species were calculated based on both quantification methods (fig. 5C). PLS
based multivariate calibration resulted in mass balances in the range 83%-109 % and analytical
chromatography resulted in mass balances 86%-104 %. This result corresponds with the higher
accuracy of the chromatographic assay. Further, a tendency of a lower overall recovery was ob-
served when using the chromatographic assay. In general, the mass balances are very acceptable
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for this type of screening. The advantages of the presented fast multivariate assay including
the high throughput (> 3 samples per min), the non-invasive and label-free methodology which
is important in case the material/proteins are needed for further experiments, and the easy
automation far outweighs the slightly lower precision compared to the assay based on analytical
chromatography.
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Figure 5: Results of the resin screening. Column 1: SP Sepharose FF, column 2: Toyopearl SP 650
M, column 3: CM Ceramic HyperD F, column 4: Fractogel EMD SO3 A: Resulting chromatogram for
each applied resin type. For each fraction, the concentration of the three protein species and the total
absorption signal is displayed. The concentrations were determined using the fast absorption spectra
based assay. Each data point represent the determined concentration using the fast absorption spectra
based assay. An assymetrical Gauss function was fitted to the data points. B: Based on the fitted curves
the chromatographic resolution of ribA-cytC and cytC-lys was calculated for both analytical approaches.
C: Based on the fitted curves the mass balances for each column were calculated for both analytical
approaches.
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4 Conclusion
An assay capable of non-invasive and label-free selective protein quantification in protein mix-
tures was successfully established. The thorough assay validation showed that it generates very
precise results. PLS was shown to generate more precise calibrations when compared to MLR
and further mean centering of the spectral data was shown to be essential for precision. To
demonstrate the applicability of the assay, it was used as analytics for an adsorber screening
performed in HTE mode. The yielded results were highly similar to those achieved by analyti-
cal chromatography, hence it can be concluded that a high reduction in analysis time without
loss of analytical information was possible. The presented methodology for selective protein
quantification therefore holds potential to help eliminate the analytical bottleneck which has
been created by the enhanced experimental throughput in downstream process development. In
future work, the impact of the number of proteins and their spectral characteristics on the pre-
cision of the method will be investigated. Further, possibilities in the area of in-line application
as process analytics for preparative chromatography will be pursued.
83
References
[1] A. Susanto, K. Treier, E. Knieps-Gru¨nhagen, E. von Lieres, J. Hubbuch, High Throughput
Screening for The Design and Optimization of Chromatographic Processes: Automated
Optimization of Chromatographic Phase Systems, Chemical Engineering & Technology
32 (1) (2009) 140–154.
[2] M. Degerman, K. Westerberg, B. Nilsson, A Model-Based Approach to Determine the
Design Space of Preparative Chromatography, Chemical Engineering & Technology 32 (8)
(2009) 1195–1202.
[3] S. Oelmeier, F. Dismer, J. Hubbuch, Application of an Aqueous Two-Phase Systems High-
Throughput Screening Method to Evaluate mAb HCP Separation, Biotechnology and Bio-
engineering 108 (1) (2011) 69–81.
[4] J. L. Coffman, J. F. Kramarczyk, B. D. Kelley, High-Throughput Screening of Chromato-
graphic Separations: I. Method Development and Column Modeling, Biotechnology and
Bioengineering 100 (4) (2008) 605–618.
[5] P. S. Wierling, R. Bogumil, E. Knieps-Gru¨nhagen, J. Hubbuch, High-Throughput Screening
of Packed-Bed Chromatography Coupled With SELDI-TOF MS Analysis : Monoclonal
Antibodies Versus Host Cell Protein, Biotechnology and Bioengineering 98 (2) (2007) 440–
450.
[6] M. Wiendahl, P. S. Wierling, J. Nielsen, D. F. Nielsen, J. Krarup, A. Staby, J. Hubbuch,
High Throughput Screening for the Design and Optimization of Chromatographic Processes
- Miniturization, Automation, and Parallelization of Breakthrough and Elution Studies,
Chemical Engineering & Technology 6 (31) (2008) 893–903.
[7] A. Susanto, E. Knieps-Gru¨nhagen, E. von Lieres, J. Hubbuch, High Throughput Screening
for the Design and Optimization of Chromatographic Processes: Assessment of Model
Parameter Determination from High Throughput Compatible Data, Chemical Engineering
& Technology 31 (12) (2008) 1846–1855.
[8] J. R. Whitaker, P. E. Granum, An Absolute Method for Protein Determination Based on
Difference in Absorbance at 235 and 280 nm, Analytical Biochemistry 109 (1) (1980) 156–9.
[9] R. K. Scopes, Measurement of Protein by Spectrophotometry at 205 nm, Analytical Bio-
chemistry 59 (1) (1974) 277–82.
[10] S. Y. Xie, R. B. Huang, L. S. Zheng, Separation and identification of perchlorinated poly-
cyclic aromatic hydrocarbons by high-performance liquid chromatography and ultraviolet
absorption spectroscopy, Journal of Chromatography A 864 (1) (1999) 173–7.
[11] K. Thoma, I. Ziegler, Simultaneous quantification of released succinic acid and a weakly
basic drug compound in dissolution media, European Journal of Pharmaceutics and Bio-
pharmaceutics 46 (2) (1998) 183–90.
[12] A. C. Mun˜oz-Mun˜oz, J. L. Pichardo-Molina, G. Ramos-Ort´ız, O. Barbosa-Garc´ıa, J. L.
Maldonado, M. A. Meneses-Nava, N. E. Ornelas-Soto, A. Escobedo, P. L. Lo´pez-de Alba,
3 PUBLICATIONS & MANUSCRIPTS
84
Identification and Quantification of Furanic Compounds in Tequila and Mezcal using Spec-
troscopy and Chemometric Methods, Journal of the Brazilian Chemical Society 21 (6)
(2010) 1077–1087.
[13] G. M. Anantharamaiah, V. K. Mishra, G. Datta, H. C. Cheung, Peptide and Protein Drug
Analysis, Informa Healthcare, 1999, Ch. 26, pp. 277–282.
[14] D. Krzyzanowska, M. Lisowski, M. Kochman, UV-difference and CD spectroscopy studies
on juvenile hormone binding to its carrier protein, Journal of Peptide Research 51 (2)
(1998) 96–102.
[15] C. O. Rock, Environment of the Aromatic Chromophores of Acyl Carrier Protein, Archives
of Biochemistry and Biophysics 225 (1) (1983) 122–9.
[16] J. Z. Porterfield, A. Zlotnick, A simple and general method for determining the protein
and nucleic acid content of viruses by UV absorbance, Virology 407 (2) (2010) 281–8.
[17] G. Escandar, P. Damiani, H. Goicoechea, A. Olivieri, A review of multivariate calibration
methods applied to biomedical analysis, Microchemical Journal 82 (1) (2006) 29–42.
[18] B. K. Lavine, Chemometrics, Analytical Chemistry 72 (12) (2000) 91–98.
[19] T. Næs, B.-H. Mevik, Understanding the collinearity problem in regression and discrimi-
nant analysis, Journal of Chemometrics 15 (4) (2001) 413–426.
85

Selective High Throughput Protein
Quantification Based on UV Absorption
Spectra
Sigrid K. Hansen1, Babak Jamali2, and Ju¨rgen Hubbuch1
1Institute of Engineering in Life Sciences, Section IV: Biomolecular Separation Engineer-
ing, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany
2CMC Project Planning & Management, Novo Nordisk A/S, Denmark
Manuscript published in Biotechnology and Bioengineering
87
3 PUBLICATIONS & MANUSCRIPTS
88
Abstract
The application of high throughput experimentation (HTE) in protein purification process de-
velopment has created an analytical bottleneck. Recently, a new label-free and non-invasive
methodology for analyzing multicomponent protein mixtures by means of spectral measure-
ments was presented. Analytics based on the methodology was shown to increase analytical
throughput for selective protein quantification significantly, however this was only demonstrated
for one particular protein combination. In this work the possibilities and limitations of the ana-
lytical method are investigated further. Principal component analysis (PCA) was performed on
a broad range of absorption spectra to investigate their common characteristics and differences.
The PCA was used both for cluster analysis and to define a measure for spectral similarity. For
binary protein combinations, the calibration precision was shown to decrease exponentially with
the defined spectral similarity factor. Knowledge of this correlation can be used to determine a
priori whether a calibration will be successful or not. Calibration robustness was investigated
by applying the analytics to liquid chromatography performed in HTE mode. Further it was
shown, that a spectral difference of 0.6% was sufficient to sucessfully preform a spectral based
calibration of two IgG1 monoclonals.
Keywords: protein analytics; analytical bottleneck; selective protein quantifica-
tion; protein UV absorption spectra; high throughput experimentation; high through-
put process development
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1 Introduction
The paradigm shift towards quality by design (QbD) as standard in the pharmaceutical industry
is progressing [1]. As QbD implies identification and evaluation of critical process parameters
and detailed documentation of their linkage to product quality, the focus of process development
has been extended beyond the sole identification of (optimal) process parameters. Hence, the
amount of sound process knowledge obtainable during the short time frame available for protein
purification process development is of increasing importance.
High throughput process development (HTPD) is a concept which can intensify the gain of
process knowledge during process development [2]. It is based on miniaturized, parallelized, and
automated unit operations for protein purification which enables a high experimental through-
put, also referred to as high throughput experimentation (HTE). In order to take HTPD beyond
traditional ‘one factor at the time’ screening, HTE is often supported by more sophisticated
approaches such as factorial designs, intelligent search algorithms or mechanistic modeling [3–5].
Today, most of the common unit operations applied for protein purification have already been
established in a HTE mode and integrated in the HTPD concept [6–10].
Univariate spectroscopic measurements performed in plate readers is the preferred analyt-
ics used in combination with HTE as it enables maintenance of the experimental throughput
and automation. We recently reported a method capable of selective protein quantification in
protein mixtures based on UV absorption spectra [11]. This method combines the advantages
of spectroscopy such as easy automation, non-invasiveness, and high throughput with the capa-
bility of selective protein quantification for which analytical chromatography or electrophoresis
would traditionally be applied.
Spectroscopy is of fundamental importance in protein science. Fields of applications range
from determination of protein conformation and reaction channels to simpler purposes such as
detection, quantification and visualization in various forms. In the particular case of protein
mid-UV (200 - 300 nm) absorption spectroscopy, physical properties of peptide bonds and a
few amino acid residues are responsible for the absorption. In Figure 1 the spectra of these
absorbing components are shown. Mainly the aromatic structures of phenyl alanine, tyrosine,
and phenyl alanine contributes to the mid-UV absorption of proteins. Each absorption spectra
of these residues exhibits two peaks, one in the area 250 – 280 nm and another at lower wave
lengths around 215 – 230 nm. Cysteine residues and peptide bonds also absorb mid-UV light,
mainly below 260 nm. The absorption of cysteine remains rather low, where as the absorption
of the peptide bonds increase strongly toward lower wave lengths. These characteristics are
Figure 1: UV absorption spec-
tra of amino acids. Spectra of
the amino acids which absorb in
the Mid-UV range are displayed
together with the spectrum of a
leucine polypeptide to also demon-
strate the absorption caused by the
peptide bonds. ............................
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text book knowledge, however the application of protein mid-UV spectra and their unique
relation to protein identity has not yet led to a wide application for selective quantification in
protein mixtures. At lower wave lengths around 190 – 210 nm mainly the peptide bonds absorb.
Hence, it is also possible to obtain information on the composition of a protein mixture via
the coefficient of e.g. the absorption at 280 nm and 205 nm. However, due to material and
apparatus issues of absorption measurements at such low wave lengths, these are often avoided.
The recently reported method for selective protein quantification based on the use of UV
absorption spectra was demonstrated to work for one particular combination of proteins. In this
work, the application is extended to a wider number of proteins to prove its general applicability.
In total, 26 proteins were included in a spectral cluster analysis to generate an overview of
spectral characteristics and variation. Further, it was attempted to define a measure for spectral
similarity which a relation to precision of the selective quantification method based on protein
spectra.
2 Materials & Methods
2.1 Disposables
PD-10 desalting columns (GE Healthcare, Buckinghamshire, UK) for buffer exchange of protein
solutions. Syringe filters with 0.22µm pore size (Millipore, Billerica, MA, USA) for filtration of
non dissolved protein. UV-grade polystyrene micro titer plates (MTP) in round 96 well half area
format and a volumetric capacity of 180µL (Greiner Bio-One, Kremsmnster, Austria) for mea-
surement of UV absorption spectra. Half micro sized UV-grade cuvettes with a working volume
≥ 1.5mL (BRAND GMBH + CO KG, Wertheim, Germany) for spectral measurements in a dou-
ble beam photometer. Square 96 well deep well plates (DWP) for preparation of elution buffer
for HTE chromatography. RoboColumns for performance of HTE chromatography prepacked
with 200µL Macro-Prep Ceramic Hydroxyapatite TYPE I, 80µm (Atoll, Germany).
2.2 Apparatus
The generation of protein samples for PLS regression model calibration and validation was per-
formed automated on a Tecan Freedom Evo 100 (Tecan, Crailsheim, Germany) liquid handling
station (LHS) equipped with 250µL dilutors. Column chromatography in HTE mode using
RoboColumns was performed on a Tecan Freedom Evo 200 LHS equipped with 1mL dilu-
tors. A thorough description of parallelized chromatography performed automated on an LHS
has been published by [12]. The used setup included a custom made column carrier. A similar
carrier is commercially available under the name Te-Chrom (Tecan, Crailsheim, Germany). Fur-
ther, the LHS was equipped with an Infinite 200 plate reader (Tecan, Crailsheim, Germany).
The LHS was operated with EVOware 2.0. Import of values for pipetting volumes and export
of spectral data was handled via Excel (Microsoft, Redmond, USA). For spectral measurements
in cuvettes, the double beam photometer Lambda 35 from Perkin Elmer (Waltham, MA, USA)
was used.
2.3 Proteins
Human insulin, hen egg white avidin and immunoglobulinG (recombinant IgG1 monoclonal)
were provided by an industrial project partner. Human insulin and hen egg white avidin were
provided in solid form and human IgG in aqueous solution at a concentration of 7 g/L. All other
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Table I: Alphabetical listing of all proteins
used in the work. The factor listed for each
protein is a spectral intensity factor, used
to normalize protein concentrations in g/L
with respect with their absorption spectra
in the range 250 - 300 nm.
No Name Origin Factor
1 avidin hen egg white 0.80
2 carbonic anhydrase bovine 0.93
3 catalase bovine 1.02
4 α-chymotrypsin bovine 0.65
5 α-chymotrypsinogen bovine 1.06
6 conalbumin hen egg white 1.07
7 concanavalin C. ensiformis 1.13
8 cytochromeC equine 0.47
9 β-glucoronidase bovine 0.76
10 glucose oxidase Aspergillus 0.84
11 hemoglobinBO bovine 0.54
12 hemoglobinHU human 0.85
13 immunoglobulinG human*1 0.72
14 insulin human*2 1.25
15 α-lactalbumin bovine 0.64
16 β-lactoglobulin bovine 1.29
17 lysozymeAV hen egg white 0.49
18 lysozymeHU human*3 0.58
19 myoglobin equine 0.58
20 ovalbumin hen egg white 1.51
21 ovomucoid hen egg white 1.83
22 ribonucleaseA bovine 1.70
23 serum albuminBO bovine 1.68
24 serum albuminHU human 1.72
25 thaumatin T. daniellii 1.06
26 transferrin bovine 0.82
*derived from trangenetic source:
1chinese hamster ovary cells 2yeast 3rice
proteins were commercially purchased in solid form (crystallized, precipitated or freeze-dried)
from Sigma-Aldrich (St. Louis, MO, USA). The proteins, their origin (for transgenic sources,
the sequence origin), and spectral intensity factor are listed in Table I.
Protein solutions for spectral measurements only, were prepared in 20mM phosphate buffer
at pH 7 with a nominal mass concentration of 1.0 g/L. This protein concentration was based
merely on weight of the protein powders and did not account for salt or other buffer components
present in the purchased solid protein preparations. Some proteins (βglucoronidase, thaumatin,
concanavalin) exhibited a solubility below 1 g/L in the used buffer. These solutions were filtered
with 0.22µm syringe filters prior to spectral measurement. Due to their low solubility, these
proteins were only included in the cluster analysis. A buffer exchange of all protein solutions
was performed to remove buffer salts or other components present in the purchased protein
preparations. The spectral intensity factors (listed in Table I) were based on the absorption
spectra in the range 250 – 300 nm of mass equivalent protein concentrations. The factor for each
protein was determined as the quotient of the mean spectral intensity of all proteins and the
spectral intensity of each single protein. Spectral intensity was defined as the sum of the 51
absorbance values contained in a spectrum.
2.4 Protein Spectra
Where nothing else is stated, protein spectra were measured in UV-grade MTPs. Each sample
had a volume of 150µL and the spectra were recorded in steps of 1 nm in the range 250 – 300 nm.
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According to manufacture’s data the bandwidth of the plate reader is 5 nm in the range used
to record the spectra. For spectral measurements used for cluster analysis, spectra of the 1 g/L
protein solutions were measured and subsequently the concentrations of these solutions were
adjusted for all spectra to give the same sum of measured absorption values. Measurements
with the Lambda 35 double beam spectrophotometer were performed with a band width of 1 nm
and recording steps of 1 nm.
2.5 Protein Difference Spectra
Difference spectra were uesd for visual comparison of protein spectra. The mean spectrum of
the spectra to be compared was calculated and then subsequently substracted from each of the
spectra to be compared.
2.6 Cluster Analysis
Prior to cluster analysis, the spectral data was preprocessed by normalization and mean cen-
tering. Hierarchical cluster analysis was performed using the MATLAB based PLS toolbox
(Eigenvector, Wenatchee, WA, USA). The hierarchical clustering was performed with Ward’s
method which is a minimum variance method and was based on principal component analysis
(PCA) of the spectral data. The hierarchical cluster was visualized as a dendrogram. Non hier-
archical cluster analysis was also based on PCA. In this case, the cluster analysis was visualized
as a scatter plot where the score of each spectrum on the 2nd PC was plotted as a function of
the score on the 1st PC.
2.7 Spectral Similarity
The determination of spectral similarity was based on PCA. By using the scores on the first three
PCs as determined by the PCA, all spectra were represented by a point in a three dimensional
space. For binary systems the spectral similarity was defined as the distance between two
protein spectra, i. e. the distance between two points representing the respective spectra in a
three dimensional space. Hence, a short distance would indicate high similarity and vice versa.
For ternary systems, the similarity was defined as the area of the triangle spanned by three
proteins, i. e. the area spanned by three points in the three dimensional space. In this case, a
small area would indicate high similarity and vice versa.
2.8 Selective Protein Concentration Calibration
Partial least squares (PLS) regression was used to calibrate multivariate models for determi-
nation of selective protein concentrations. Each calibrated PLS model was validated by an
independent sample set of defined concentrations to determine its precision. Precision was de-
fined as the coefficient of determination (R2) based on the independent validation samples. For
the binary protein combinations, the composition of calibration and validation samples was
based on a six layer onion design which consisted of 16 samples. For ternary and quaternary
proteins combinations, the composition of calibration and validation samples was based on a
four layer onion design which consisted of 32 samples for ternary systems and 40 samples for
quaternary systems. The designs were generated with MODDE (Umetrics, Ume˚a, Sweden).
The binary and ternary protein calibrations were performed in a concentration range from
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0 – 0.4 g/L and the quaternary calibration was performed in the concentration range from 0 –
0.2 g/L. For each protein combination, two sample sets were prepared of which the first was
used for calibration and the second for validation. For calibration and validation, the MATLAB
based PLS toolbox (Eigenvector, Wenatchee, WA, USA) was used. Calibration and validation
samples were prepared on the LHS from stock solutions with a concentration of 0.8 g/L for
binary and quaternary systems and 1.2 g/L for ternary systems. All mentioned concentrations
are spectral intensity corrected concentrations. The true concentrations of the stock solutions
were determined according to the spectral intensity factor of each protein as listed in Table I.
In order to prepare a spectral intensity corrected protein solution with a nominal concentra-
tion of 0.8 g/L of e.g. lysozymeHU, the intended nominal concentration was multiplied with
lysozymeHU spectral intensity factor to give the actual concentration of the solution.
2.9 Column Chromatography
All columns were equilibrated with five column volumes (CV) loading buffer (1 mM sodium
phosphate, pH = 6.8) before loading protein on to the columns. The amount of protein loaded
to the columns was adjusted according to spectral absorption intensity of each protein. A
nominal concentration of 5 g/L was multiplied with the spectral intensity factor to produce
the actual concentration of protein in the load solution. Of the protein load solution, 50µL
were loaded to the column. Before starting the actual column experiments, 18 different buffer
solutions with increasing sodium phosphate concentrations were prepared and stored in DWPs
until use. The prepared buffer solutions composed a linear step gradient from 1 – 300mM sodium
phosphate at pH 6.8 over 18CV. Each gradient step was collected as one elution fraction. After
completed elution, 150µL of each elution fraction were transferred into UV grade MTPs and the
absorption spectra were measured. Based on these spectra, the protein content in the samples
was determined using previously calibrated PLS regression models as described in section 2.8.
3 Results & Discussion
It has recently been shown that mid-UV absorption spectra can be applied to perform selective
protein quantification in protein mixtures. To demonstrate a broad application of the method,
many different proteins have been included in this work. An overview of spectral variety among
the proteins was generated and followed by an investigation of the relation between spectral
similarity and calibration precision.
3.1 Clustering
3.1.1 Dendrogram
order to obtain a preliminary overview of the spectral data, a hierarchical cluster analysis was
performed and visualized in the form of a dendrogram (Figure 2A). Within the 26 protein spectra
five clusters were identified and labeled 1 – 5. Cluster identification was based on the increase in
variance within each cluster with decreasing number of clusters as plotted in Figure 2B. Below
five clusters the maximal variance within the clusters increases significantly and hence this point
was chosen as threshold for cluster identification. Cluster 4 had the highest variance of ∼ 0.5
and cluster 1 the lowest variance of ∼ 0.3. The clusters 2, 3, and 4 had a variance of ∼ 0.4.
When looking at the spectra in Figure 2C on which the dendrogram is based, the clusters 1 and
2 (green and red) can easily be identified from the complete set of curves by visual inspection,
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Figure 2: PCA based cluster identification based on spectral data. A: From 26 protein spectra a PCA
based dendrogram was computed to give an overview of spectral similarity. In the dendrogram, five
clusters were identified (labeled 1, 2, 3, 4, and 5) and given different main colors. B: Decrease in the
number of clusters as a function of the variance within each cluster. C: All Spectra in the color of each
respective cluster. D: Difference spectra of all measured spectra. E-N: Spectra of single clusters colored
as the respective clusters in the dendrogram and to the right of each cluster the respective difference
spectra.
however the clusters 3, 4, and 5 are more difficult to distinguish. In Figure 2E,G, I,K, andM,
the spectra of each cluster are plotted separately. Here, the significant traits of all clusters
become visible. Cluster 1 has the least internal variance and is also the most isolated cluster.
All of the proteins in this cluster are heme proteins, and the heme group is assumed to cause
the characteristic flat shape of these spectra. Cluster 2 consists of only two spectra with a very
narrow shape in the range 260 – 300 nm. These are spectra of human insulin and ribonucleaseA
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both of which contain no tryptophan. This explains their narrow shape, as tryptophan has
a broader spectrum compared tyrosine and above 290 nm tryptophan is the sole contributor
to absorption (see Figure 1). The spectra of cluster 3 are broader in the range 260 – 300 nm
compared to the spectra of cluster 2 and the spectra of cluster 4 and 5 follows the pattern
of the spectra becoming broader. As the spectra becomes broader, the shoulder at 290 nm
becomes more distinct which specifically indicates an increase in tryptophan content. Hence,
the hierarchical cluster analysis generated clusters mainly based on the relative tryptophan
content in the proteins with an increase in tryptophan content through cluster 2 to 5. This
correlates with the fact that tryptophan is the strongest contributor to the UV absorption
spectra with a seven times stronger absorption per mole in the 250 – 300 nm when compared to
tyrosine and 70 times stronger when compared to phenyl alanine. The observation that many
of the spectra exhibits an increase in absorption below 255 nm does not correlate with the pure
spectra of the aromatic amino acids and can also not be explained by the cysteine residues
or peptide bonds alone. The observation is most likely due to a solvatochromic effect, as the
aromatic amino acids are mostly situated in the hydrophobic core of a native protein and not
in hydrophilic surroundings as the aqueous buffer in which the were in fact measured.
3.1.2 PCA Scatter
Hierarchical clustering provides a helpful overview of the spectral data, however the quanti-
tative measure obtained is only the distance between cluster centers and when ascending in
the hierarchy only distance between merged cluster centers. Therefore, it can not be used to
give a measure on the spectral similarity of every random combination of proteins. In order
to obtain a quantitative measure and visualization of spectral similarity of all spectra, PCA
was performed and visualized as a scatter plot. PCA is a projection method, which is able to
condensate significant information from larger data sets. Figure 3 shows the resulting scatter
plot of the scores on two first PCs for each protein spectrum included in the PCA.
The PCA showed that two PCs described 96.6% of the variation in the spectral data with
55.52% described by the first PC and 40.48% described by the second PC. The third PC
described 2.2% and is also considered relevant, however the plot was limited to the display of
two dimensions in order to simplify the visual interpretation. The data points are colored with
respect to cluster belonging as determined by the hierarchical chluster analysis. The clusters
identified by the hierarchial cluster analysis corresponded well to the PC scatter plot, i. e. each
color symbolizing cluster belonging as determined by the hierarchial cluster analysis also forms a
cluster in the PC scatter plot. In the scatter plots, the clusters of narrow spectra are positioned
to the left and the clusters move to the right and downwards as the spectra gets broader (see
spectra of single clusters in Figure 2).
Seven of the protein spectra were used to validate the PCA model. These are displayed as
triangles in the scatter plot. Their positions correlate with the main clusters determined by the
hierarchical cluster analysis, i. e., avidin is closest to α-chymotrypsinogen and α-chymotrypsin,
α-lactalbumin is closest to lysozymeAV, and so forth. This indicates that the PCA model
has predictive power and can be used to determine the similarity of protein spectra not used
to build the initial PCA model. This is important as the idea was to establish a correlation
between spectral similarity and possible precision obtainable for a calibration of selective protein
concentrations based on UV spectra. If the PCA model has predictive power and a correlation
is established between spectral similarity and calibration precision, the PCA model can be used
to give an a priori estimate on the precision of a calibration.
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Figure 3: PCA based scatter plot of spectral data. Principal component plot of the protein spectra
in which each data point represent the scores on the 1st and 2nd principal component as calculated
from one protein spectrum. The data points are colored with respect to the clusters defined by the
dendrogram cluster analysis (see fig. 2A). Eight spectra were chosen to validate the PCA model and
their the corresponding data points are represented by triangles.
As in the dendrogram, the scatter plot shows that cluster 1 is the most isolated cluster.
However, the fact that cluster 2 is the second most isolated cluster is an information which
could not have be derived from the dendrogram. Further, it would not have been possible to
identify whether e. g. cluster 1 is more or less similar to any of the other clusters without looking
at the actual spectra from the clusters. From the scatter plot this can be determined by looking
at the distance between each cluster center. As can be seen, the distances from cluster 1 to the
centers of cluster 3 and 5 are similar (∼ 0.3) and the distance to cluster 3 is a bit shorter (∼ 0.25).
Accordingly, the similarity between any two spectra can be determined from the scatter plot.
3.2 Calibrations
In order to get a measure for the similarity of the measured protein spectra, each spectra
was defined by its principal component scores on the first three principal components. For a
binary systems, the similarity was then defined as the distance and for ternary systems the
similarity was defined by the spanned area. The determined similarities were set in relation
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Figure 4: Protein spectra and
calibration validation of four bi-
nary protein combinations. A-
D: Protein spectra of four of the
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to the calibration precision achieved for each of the respective systems in order to investigate
the correlation between these two parameters. A low spectral similarity value indicates a high
spectral similarity and vise versa.
3.2.1 Binary systems
PLS regression models were calibrated for eleven different protein combinations. All models
were validated with independent samples and the precision of each calibrated PLS regression
model was defined as the coefficient of determination based on the respective validation sam-
ples. In Figure 4 the spectra of four protein combinations with increasing spectral similarity
are shown along with validation results. There is a clear correlation between spectral similar-
ity and precision at the extremes of high or low spectral similarity (Figure 4A/E and D/H),
however when comparing the systems in between the picture becomes ambiguous. In Figure 5B
and C the spectra and calibration curves of the systems serum albuminHU/ovomucoid and
myoglobin/hemoglobinHU are displayed. Both systems achieved the same calibration precision
of 0.997 even though the spectral similarity factors were very different, i. e. 0.0057 for myo-
globin/hemoglobinHU and 0.0145 for the serum albuminHU/ovomucoid system. In Figure 5A
the determined calibration precision for all binary systems is shown as a function of determined
spectral similarity. The validation of the calibrated PLS regression models revealed coefficients
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Figure 5: Calibration of selec-
tive protein concentrations based
on recorded UV spectra includ-
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protein combination. A: Coeffi-
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of determination ranging from 0.975 to > 0.999. The most precise calibration was achieved for
the ribonucleaseA/cytochromeC system which is also the least similar system with a spectral
similarity of ∼ 0.052 and these proteins also had the two most different spectra of all measure
spectra. The least precise calibration was achieved for the lysozymeAV/α-lactoglobulin system
which correlated with the fact that these proteins exhibited the highest spectral similarity with
a similarity factor of 0.0016.
The before mentioned example of protein combinations with rather different spectral sim-
ilarity factors resulting in identical precision, represents an extreme value in presented data,
however it does mark a general trend that calibrations of proteins from cluster 1 and 5 are
more precise than calibrations from cluster 2, 3, and 4. The PCA analysis on which the de-
termined spectral similarities were based, was evaluated by an external data set consisting of
seven protein spectra. Many of these spectra were of proteins used in the calibration experi-
ments. Data points represented by triangles are systems where both proteins were used for PCA
validation. In all other systems one of the proteins was used for validation, with exception ri-
bonucleaseA/cytochromeC and ribonucleaseA/insulin all of which were not used for validation.
Systems consisting of two proteins of which the spectra were used for validation, does neither
create nor disturb the general trend of the cluster belonging having an influence on calibration
precision and can therefore not explain the observation. As reflected by the spectral intensity
99
factors listed in Table I, a lower absorbance per mass unit was characteristic for the proteins
from the clusters 2, 3, and 4. Because the protein solutions were prepared to have the same
absorption intensity in the recorded spectral range, the applied protein solutions had different
mass concentrations. The rationale for the spectral intensity corrections of the used protein
concentrations, was based on the assumption that proteins with a low spectral intensity would
otherwise be more influenced by noise. To exclude this effect, mass concentrations corrected for
spectra intensity were used. The stock solutions used to prepare the calibration samples were in
the range 0.47 – 0.84 g/L for proteins from cluster 1 and 5 and 1.25 – 1.83 g/L for proteins from
cluster 2, 3, and 4 (see Table I). It has been described that increasing protein concentration
decreases the surface tension of aqueous protein solutions [13]. Liquids with a relative lower
surface tension tends to be more difficult to pipet and this could explain the differences in
calibration precision which can not be explained by the difference in spectral similarity alone.
Further, the surface tension also influences the surface geometry of a liquid in a MTP well. Pure
buffer has a straight surface and with decreasing surface tension (increasing protein concentra-
tion) the surface warps into meniscal shape [14]. As the light beam passes vertically through
the samples in a plate reader, the shape of the horizontal surface influences the light path length
and amount of scattered light and, hence, the measurement precision.
The precision of PLS regression models based on protein UV spectra is only comparable
with analytical chromatography in the most favorably cases, as generally a coefficient of deter-
mination above 0.999 can be expected of an HPLC based protein quantification assay. Only
the system with the two proteins having most different spectra achieved a calibration with a
comparable precision. The necessary precision of a given calibration of course depends on the
application and therefore no absolute measure for the necessary spectral difference. Nine out of
eleven protein combinations resulted in a coefficient of determination ≥ 0.995. For all combina-
tions with a spectral similarity factor ≥ 0.01, the coefficient of determination was ≥ 0.995. For
many HTE applications, this is thought to be sufficient. Further, the advantages of the method
would in many cases compensate the trade off in precision.
3.2.2 Ternary Systems
PLS regression models were calibrated for six ternary protein combinations and validated with
independent samples sets. Based on the validation samples, the precision of each calibration
was determined. For ternary systems, the spectral similarity factor was defined as the area of
the triangle spanned by the PC scores of the three spectra. Figure 5B displays each determined
coefficient of determination as a function of the respective spectral similarity factor. Each system
had been calibrated twice; once where the PLS regression model was based on three latent
variables and once based on four latent variables. The precision of the PLS regression models
based on three latent variables decreased from 0.993 to 0.798 with decreasing spectral similarity
factor. However, only the endpoints exhibited a clear correlation. Of the four combinations
in between, the two ternary combinations with proteins from the clusters 2, 3, and 4 exhibit a
local decrease in precision with a decrease in spectral similarity factor and the same observation
was made for the two combinations with proteins mainly from the clusters 1 and 5. As the two
last mentioned protein combination exhibited the highest precision of these four combinations,
the previously observed trend that binary protein combinations from cluster 1 and 5 result in
more precisely calibrated PLS regression models recurs for ternary protein mixtures where the
calibration was based on three latent variables. In all cases where the calibration had been
based on four latent variables the precision was significantly higher compared to those based
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Figure 6: Validation result of a
four component calibration. Dis-
played are the results obtained by
two different photometers: left -
single beam plate reader, right:
double beam cuvette photome-
ter. For each component the data
points represent the determined
protein concentration vs. nominal
concentration. ............................
...................................
on three latent variables. Further, the overall decrease in precision between the endpoints
is less pronounced. For the two protein combinations with the lowest spectral similarity the
determined coefficient of determination was 0.997 and for the four protein combinations with
the highest spectral similarity 0.988 ± 0.06%.
3.2.3 Quaternary Systems
The possibility to calibrate protein concentration with absorption spectra in a quaternary pro-
tein mixture consisting of lysozymeAV (lys), ribonucleaseA (rib), serum albuminHU (HSA),
and serum albuminBO (BSA) was investigated. The spectra of the calibration and validation
samples were measured with two different photometers: the single beam plate reader used to
measure all other spectra and a double beam photometer which required the use of cuvettes
as sample container. The calibration results based on both photometers are shown in Figure 6
(left column: plate reader, right column: double beam photometer). The calibration precision
achieved with the double beam photometer was higher for all four proteins. As can be seen,
the effect is considerable and is explained by the higher resolution and precision of the double
beam photometer as well as the changed sample container geometry used herein. The effect of
the sample container is due to the fact that protein solutions in MTP wells exhibit a convex
surface which causes both path length inaccuracy and a higher amount of light scattering which
both affect the quality of the recorded spectra.
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Figure 7: Validation result of a
two component IgG calibration. A-
B: Spectra and difference spec-
tra of the two IgGs. C-D: For
each IgG, the data points repre-
sent the experimentally determined
IgG concentration vs. nominal
concentration. ............................
...................................
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The achieved precision for each of the four components was rater different, however with
the same ascending order lys> rib>HSA>BSA for both photometer types. Lys achieved a
coefficient of determination ≥ 0.999 using both photometers. Also rib achieved a coefficient
of determination = 0.999, however only using the double beam photometer. The coefficients
of determination for HSA and BSA were ∼ 0.99 for the double beam photometer and ∼ 0.9
for the single beam plate reader. The two of the four proteins with the highest similarity are
BSA and HSA which are both from cluster 3 (spectral similarity factor: 0.012). This correlates
with the lower precision of the calibration for those two proteins. As can be seen in the PCA
scatter plot (Figure 3), the BSA spectrum has a higher similarity to the spectra of rib and lys
than the spectrum of HSA. This correlates with the finding that the precision for BSA was the
lowest of all four components. However, the fact that the calibration was less precise for rib
than for lysA can not be explained by differences in spectral similarity, as both components
have very similar spectral similarity factors when set in relation to BSA and HSA (rib/HSA =
0.0179, lys/HSA = 0.0183, rib/BSA = 0.0230, lys/BSA = 0.0216). The finding does however
correlate with the previous finding that proteins of which the spectra were assigned to cluster 1
and 5 generated calibrations of higher precision compared to proteins of which the spectra were
assigned to the clusters 2, 3, and 4. Thus, the very different degrees of precision seems to be
caused by a combination the cluster related spectral intensity factor (listed in Table I) and the
different spectral similarities of the four proteins.
3.3 Case Study I: Calibration of two Monoclonal IgGs
In Figure 7A, the spectra of two different monoclonal IgGs (In the following termed IgG-01 and
IgG-02) are shown. As can be seen, the spectral similarity for these two proteins is very high
and by visual inspection of the spectra, almost no difference can be determined. The differ-
ence spectra (Figure7B), however, reveals spectral differences in the range ∼ 2 – 8mAU which
is approximately 0.5% of the average spectral signal (average spectral difference 3.57mAU and
average spectral signal 0.62 AU). The spectral similarity factor for the two IgGs calculated on
basis of the PCA analysis was 0.0009. According to the investigated binary protein combi-
nations, a calibration based on the spectra of these two IgGs should result in a coefficient of
determination well below 0.975 (see Figure 5B) which was the coefficeint of determination mea-
sured for the lysozymeAV/α-lactalbumin combination. Hence, based on the initial studies of
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the IgG spectra, a calibration was predicted to be of low quality. However, the study including
four proteins measured in cuvettes in the double beam photometer, had demonstrated how it
was possible to increase precision by changing measurement instrument and sample container.
Hence, a calibration of the two IgGs was attempted using cuvetts and the double beam pho-
tometer. In the calibrated range 0 – 0.8 g/L, this resulted in a coefficient of determination of
0.994 for IgG-01 and 0.992 for IgG-02. To emphasize the increase in precision, the samples
were also measured in MTP and as expected this resulted in a significantly lower calibration
precision (IgG-01: R2 = 0.944 and IgG-02: R2 = 0.932).
3.4 Case Study II: HTE Chromatography
The presented analytical method enables non-invasive and label-free selective protein quantifi-
cation performed automated on an LHS. Hence, the method is a valuable addition to univariate
spectroscopic analytics or even a replacement of other selective quantification methods such as
analytical chromatography or electrophoresis. HTE chromatography is a setup of miniaturized
and parallel chromatography performed automated on an LHS. In order to demonstrate the
presented methods applicability, HTE chromatography was performed with two binary protein
combinations of different spectral similarity. Different degrees of spectral similarity were chosen
to check for agreement with the previously demonstrated correlation between spectral simi-
larity and calibration precision. The two protein combinations were serum albuminBO/serum
albuminHU (BSA/HSA) from cluster 3 and and lysozymeAV/lysozymeHU (lysA/lysH) from
cluster 5 (see Figure 2). Of the two combinations, lysA/lysH had the highest spectral similar-
ity with a spectral similarity factor of 0.005 where as the combination BSA/HSA had a lower
spectral similarity with a spectral similarity factor of 0.012 (see Figure 4). The precision of
the calibrated regression models was highest for the BSA/HSA combination (R2= 0.995) and
somewhat lower for lysA/lysH combination (R2= 0.991).
3.4.1 HTE Chromatogram Evaluation
Four column runs were performed per protein combination: one blank, one with both proteins,
and two with pure proteins. The Figures 8A-D display the UV280 traces and the spectral fit error
of the four column runs related to the BSA/HSA combination. Below those, in Figure 8E-G,
the respective selective protein concentrations are shown. In Figure 8I-P the equivalent data for
the lysA/lysH runs is displayed. The spectral fit error is a measure for the part of a spectrum
which cannot be fitted to the PLS regression model calibrated for the protein combination
in question. Causes therefore can be regular noise, influences of salt in the elution buffer, or
separation of impurities present in the purchased protein preparations and hence calibrated into
the PLS regression model with the main protein components. If the latter would be the case,
the spectra of all fractions in which the co calibrated components are no longer present in the
original ratio, will be partly unknown to the calibration model. The severity of the impact on
the determination of selective protein concentrations will depend on the spectral differences. If
the noise level is constant and no ‘impurity separation’ occurs, the spectral error is expected to
be proportional to the UV signal intensity. This was the case for the lysA/lysH combination,
however, not for the BSA/HSA combination. This could indicate that the purchased lysozyme
preparations were of higher purity compared to the serum albumins. However, both lysA
and lysH eluted from the RoboColumns in only 2-3 fractions and almost no separation of the
two proteins was achieved. Hence, potential impurities would most likely coelute with the
lysozyme species and a possibly impurity ratio would therefore remain identical to that of the
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Figure 8: HTE chromatography performed with RoboColumns. In the HTE chromatograms the UV280
value, the spectral error value, and the selective protein concentrations as determined in each collected
fraction are displayed. The HTE chromatograms displaying protein concentrations are all located below
the respective chromatogram showing the UV280 values. The first column (A,E, I,M) shows the HTE
chromatograms of the blank runs where only buffer was loaded to the RoboColumns. The second column
(B, F, J,N) displays the HTE chromatograms of both protein combinations (serum albuminHU/serum
albuminBO and lysozymeHU/lysozymeHU). The two last columns (C,D,G,H,K, L,O, P) displays the
HTE chromatograms of each single component.
calibration. The fact that the spectral error was higher in the lysA/lysH run when compared
to the single protein runs might caused by to the high protein concentrations in the elution
fractions which required a significant extrapolation of the original lysA/lysH calibration. The
protein concentrations of the blank run exhibited a baseline drift for both lys signals in opposite
directions. The baseline drift of both lys protein signals also occurred in all three runs with
protein. The runs with only lysA or lysH, revealed a positive interaction of the protein signals.
This is most likely due to an inaccuracy in the calibration of the very similar spectra. Apart
from the interaction, the selective concentration profiles of the single component runs matched
the UV280 profiles of the respective runs very well. Further, they also matched the selective
protein signals of the lysA/lysH run.
The spectral fit error for the BSA/HSA combination was approximately one to two orders of
magnitude lower when compared to the lysozymeAV/lysozymeHU combination. This correlated
with the lower similarity of the serum albumin spectra, however it is not understood whether the
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Mass Balances (%)
Proteins serum albuminBO serum albuminHU
loaded: UV250−300 UV280 UV250−300 UV280
serum albuminHU/BO 114 101* 85 101*
serum albuminBO 95 102 -7** -
serum albuminHU 8** - 82 98
Proteins lysozymeHU lysozymeAV
loaded: UV250−300 UV280 UV250−300 UV280
lysozymeAV/HU 102 92* 84 92*
lysozymeHU 87 102 6** -
lysozymeAV 11** - 91 93
*Identical mass balance values for both proteins, as UV280 based quan-
tification only enables quantification of total protein content
**hypothetical mass balance based on the nominal mass of the protein
loaded to the column
Table II: Listing of protein
mass balances for the HTE
chromatography runs. Mass
balances were calculated us-
ing both traditional univari-
ate total protein quantifica-
tion (UV280) and selective
quantification based on ab-
sorption spectra (UV250−300).
In Figure 6, which displays
the HTE chromatograms, the
gray areas indicate the frac-
tions on which the presented
mass balances are based.
correlation is causal. The selective protein concentrations of the blank run exhibited a baseline
drift for both proteins in opposite directions of each other. The baseline drift of both serum
albumin protein signals also occurred in all chromatograms with protein. In the BSA run, the
error signal at first correlated with the intensity of the UV280 signal and then increased again
through the ‘shoulder’ of the BSA peak. However, the noise level was only slightly higher than
for the blank run. The HSA run exhibited a significantly higher spectral error when compared to
the BSA run and also did not follow the course of the UV280 signal. This indicated the presence
of one or more impurities in the purchased HSA, which had been at least partly separated on
the column. This was reflected in the protein signals of HSA in the HTE chromatograms of
both runs with HSA. In the HSA run, the first two fractions (fraction 5 and 6) of which the
UV280 signal indicated eluting protein, the HSA signal exhibited negative values. At the same
time, the BSA signal exhibited positive values even though this protein was not present. By
subtracting the BSA signal of the HSA run from the BSA signal of the BSA/HSA run, the BSA
signal of the BSA/HSA run became very similar to the BSA signal of the BSA run (data not
shown). This supports the assumption of an impurity in the purchased HSA to be the cause
of the differences in the elution profiles of BSA in the two runs with BSA. Apart from the
interactions caused by the impurity present in HSA and the baseline drift, the selective protein
signals of the single component runs correlated with the UV280 signals.
For both protein combinations, the baseline of the blank runs deviated from zero and in
both cases the calculated protein concentration of one component mirrored the other around
the x-axis. Due to the stable baseline of the UV280 signal at zero and also the mirrored curse of
the selective concentrations, it is unlikely that these protein signals were caused by elution of
protein remains from earlier runs. More likely, it is an calibration artifact as the baseline course
of the blank runs also repeat in the runs with protein. It might be caused by a combined effect
of increasing phosphate concentration in the buffer and difficulties of the calibrated model to
cope with spectra of low intensity.
3.4.2 Mass Balance Evaluation
For the calculation of the mass balances, it was assumed that the baseline drifts were static and
not dependent on protein concentration. Hence, for the mass balance calculations, a baseline
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correction was undertaken by subtracting the baseline signals of the blank runs from the protein
signals in the runs with protein. The mass balances were calculated based on the gray marked
area in the HTE chromatograms. For comparison, also mass balances based on the UV280 signal
were determined. All mass balances are listed in Table II.
The mass balances of the BSA/HSA runs exhibited a higher variability (82 - 114% - mean: 94%)
in comparison to the lysA/lysH runs (84 - 102% - mean: 89%) when based on selective protein
concentrations. For the BSA/HSA runs the UV280 based mass balances indicated correct mass
recovery (98 - 102% - mean: 101%). Hence, deviations in the mass balances based on the se-
lective protein signals cannot be ascribed to general inaccuracies or errors in the experimental
setup. In the BSA run, the mass balance was 95% for BSA and -7% for HSA when based on the
selective protein concentrations and 102% when based on UV280. This indicates an interaction
between the two components in the applied calibration, which could not be eliminated by the
performed baseline correction alone. The low recovery for HSA in the HSA run was most likely
cuased by partly separated impurites present in the purchased HSA. This is caused by the fact
that the previously calibrated model cannot know the spectra of partly separated impurities.
Therefore, the concentrations calculated after the inpurities were separated from the main pro-
tein component would be faulty (see Figure 6F,H). The 8% BSA identified in this run was most
likely also due to the faulty concentration determination due toimpurity separation, possibly in
combination with onter interactions not eliminated completely by the baseline correction. In
the BSA/HSA run, the mass balances based on the selective protein concentrations reflected
the behaviour of the single component runs. The mass balance for BSA was > 100% as HSA
alone creates a netto positive signal for BSA and vice versa.
The mass balance variability of the lysA/lysH runs was lower compared to the HSA/BSA
runs when based on selective concentration (84 - 102% - mean: 89%). However, the UV280
based mass balances for the lysA/lysH runs exhibited a higher variablity and a lower mean
value when compared to the BSA runs. This indicated an incomplete mass recovery (92 - 102%
- mean: 94%) in the lys runs. In the run with both lysA and lysH, the mass balances based
on selective concentrations showed a higher recovery for lysH (102%) than for lysA (84%).
This difference correlated with the interaction determined in the single component runs; in the
lysA run 11% lysH was detected and in the lysH run 6% lysA was detected. The mean value
of the mass balance based on selective concentrations (93%) were very similar to the mass
balance based on UV280. As lysA and and lysH eluted from the column in a small volume,
the concentration in the fractions was generally higher compared to the fractions with BSA
and HSA. Hence, the high protein concentration in the run with both lysA and lysH possibly
exeeded the range of correct extrapolation for both the univariate UV280 based calibrations and
the spectral based calibration of the respective PLS regression model. This would then explain
the lower recovery. The fact that the UV280 based mass balance for the run with only lysA
was only 93 % might indicate some experimentral error as the absorption intensity was not
considerably higher than the run with HSA/BSA or lysH.
Even though the combination lysA/lysH had a higher spectral similarity compared to
BSA/HSA, the HTE chromatograms of lysA/lysH did not exhibit a lower quality. For both
protein combinations, the elution profiles based on selective concentration matched the UV280
elution profiles very well. For the BSA/HSA combination, an even better result could have been
achieved if the applied HSA had been of a higher purity. If so, the mass balances for BSA and
HSA based on selective protein concentrations would be expected to have a higher accuracy.
This might also show a more significant effect of the lower spectral similarity of BSA/HSA
compared to lysA/lysH which in theory should generate chromatograms of higher accuracy for
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HSA/BSA. However, it was clearly demonstrated that it is possible to generate selective con-
centration elution profiles which contained much more information than a respective univariate
UV trace.
4 Conclusion and Outlook
The investigation into spectral similarities of a broad range of proteins based on hierarchical
and non hierarchical cluster analysis determined five groups of proteins with similar spectral
characteristics. One group was comprised of heme proteins whereas the other four groups
were defined primarily by tryptophan content. By principal component analysis, a measure for
spectral similarity was defined for bi- and ternary protein combinations. As previously demon-
strated, selective high throughput protein quantification can be performed based on protein
absorption spectra. For binary protein combinations, the precision of the quantification was
shown to decrease exponentially with spectral similarity. The PCA model used as basis for
spectral similarity determination was shown to have predictive power. Hence, it can be used to
predict the possible precision of the method when used for quantification of proteins unknown to
the PCA model. This can help estimate a priori whether a certain calibration will be successful
for the purpose intended, i.e., whether the achieved precision will be adequate.
The finding that instrument device and sample container both play a crucial role for the
achievable calibration precision, was tested for a combination of two monoclonal IgGs for which
the PCA analysis had indicated that calibration would not be successful using MTP and UV
plate reader. It was demonstrated, that even for monoclonal IgGs with a spectral difference
below 1% it was possible to achieve a coefficient of determination > 0.99 when using a double
beam photometer and cuvettes as sample container.
For ternary combinations, no clear correlation was established between spectral similarity
and precision, suggesting that the defined measure for spectral similarity of ternary protein
combinations did not stand in direct relation to method precision. Future work will be aimed
at finding a measure for spectral similarity with a clear relation to method precision also for
ternary protein combinations. Further, as the ternary protein combinations also resulted in
precise calibrations, further efforts will be dedicated to demonstrate their general robustness
when used as analytics for HTE.
On the basis of liquid chromatography, which is a widely used unit operation for protein
purification, a HTE application of spectral based selective protein quantification was successfully
demonstrated. The application is of course not restricted to HTE chromatography and can be
applied as high throughput analytics for practically any unit operation where selective protein
quantification is required. The complexity of the quantification task in question and the required
detection limits and precision will determine whether an application will be successful. However,
as the demonstrated application was perpharmaceutiske fed with proteins of very high spectral
similarity we expect that this will often be the case.
107
References
[1] A. S. Rathore, H. Winkle, Quality by design for biopharmaceuticals, Nature Biotechnology
27 (1) (2009) 24–36.
[2] R. Bhambure, K. Kumar, A. S. Rathore, High-throughput process development for bio-
pharmaceutical drug substances., Trends in biotechnology 29 (3) (2011) 127–35.
[3] S. Oelmeier, F. Dismer, J. Hubbuch, Application of an Aqueous Two-Phase Systems High-
Throughput Screening Method to Evaluate mAb HCP Separation, Biotechnology and Bio-
engineering 108 (1) (2011) 69–81.
[4] A. Susanto, K. Treier, E. Knieps-Gru¨nhagen, E. von Lieres, J. Hubbuch, High Throughput
Screening for The Design and Optimization of Chromatographic Processes: Automated
Optimization of Chromatographic Phase Systems, Chemical Engineering & Technology
32 (1) (2009) 140–154.
[5] M. Degerman, K. Westerberg, B. Nilsson, A Model-Based Approach to Determine the
Design Space of Preparative Chromatography, Chemical Engineering & Technology 32 (8)
(2009) 1195–1202.
[6] M. Bensch, P. S. Wierling, E. von Lieres, J. Hubbuch, High Throughput Screening of Chro-
matographic Phases for Rapid Process Development, Chemical Engineering & Technology
28 (11) (2005) 1274–1284.
[7] C. Dinter, a. Schuetz, T. Blume, H. Weinmann, M. Harre, H. Neh, Automated Solubility
Determination Using a Customized Robotic System and a Turbidity Probe, Journal of the
Association for Laboratory Automation 10 (6) (2005) 408–411.
[8] M. Bensch, B. Selbach, J. Hubbuch, High throughput screening techniques in downstream
processing: Preparation, characterization and optimization of aqueous two-phase systems,
Chemical Engineering Science 62 (2007) 2011 – 2021.
[9] P. S. Wierling, R. Bogumil, E. Knieps-Gru¨nhagen, High-Throughput Screening of Packed-
Bed Chromatography Coupled With SELDI-TOF MS Analysis : Monoclonal Antibodies
Versus Host Cell Protein, October 98 (2) (2007) 440–450.
[10] J. L. Coffman, J. F. Kramarczyk, B. D. Kelley, High-Throughput Screening of Chromato-
graphic Separations: I. Method Development and Column Modeling, Biotechnology and
Bioengineering 100 (4) (2008) 605–618.
[11] S. K. Hansen, E. Skibsted, A. Staby, J. Hubbuch, A label-free methodology for selective
protein quantification by means of absorption measurements., Biotechnology and bioengi-
neering 108 (11) (2011) 2661–2669.
[12] M. Wiendahl, P. Schulze Wierling, J. Nielsen, D. Fomsgaard Christensen, J. Krarup,
A. Staby, J. Hubbuch, High Throughput Screening for the Design and Optimization of
Chromatographic Processes Miniaturization, Automation and Parallelization of Break-
through and Elution Studies, Chemical Engineering & Technology 31 (6) (2008) 893–903.
[13] T. Okubo, K. Kobayashi, Surface Tension of Biological Polyelectrolyte Solutions., Journal
of colloid and interface science 205 (2) (1998) 433–442.
3 PUBLICATIONS & MANUSCRIPTS
108
[14] M. G. Cottingham, C. D. Bain, D. J. T. Vaux, Rapid method for measurement of surface
tension in multiwell plates., Laboratory investigation; a journal of technical methods and
pathology 84 (4) (2004) 523–9.
109
3 PUBLICATIONS & MANUSCRIPTS
110
In-line Analytics for Preparative
Chromatographic Separations Based on
Multivariate Calibration of Protein
Spectra
Sigrid K. Hansen1, Arne Staby2, Erik Skibsted2, Ju¨rgen Hubbuch1*
2Institute of Engineering in Life Sciences, Section IV: Biomolecular Separation Engineer-
ing, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany
2 CMC Project Planning & Management, Novo Nordisk A/S, Denmark
* Corresponding author. Tel.: +49 721 608-2557; fax: +49 721 608-6240. E-mail address: juer-
gen.hubbuch@kit.edu
Presented at the European Congress of Applied Biotechnology 2011, Berlin
111
3 PUBLICATIONS & MANUSCRIPTS
112
Abstract
Online analysis of quality attributes (CQA) during biopharmaceutical processing is an essential
part of the process analytical technology (PAT) concept (PAT Guidance for Industry – A
Framework for Innovative Pharmaceutical Development, Manufacturing and Quality Assurance,
FDA 2004 [1]). The goal is to enable management of batch variability and deviations of critical
process parameters by using in-line and on-line analysis. In this way, consistent quality of the
processed product can be assured and batch rejections can be avoided. Liquid chromatography
is one of the most applied unit operations in purification of biopharmaceuticals. In most cases,
the peak cutting criteria is the most important process parameter to be controlled during
product elution. Commonly, the peak cutting decision is based on elution volume or univariate
absorption measurement. Recently, a new method for selective protein quantification based on
mid-UV protein absorption spectra was presented. The method applied multivariate calibration
to link the information in the absorption spectra to the selective protein concentrations present
in a sample. In the presented form, a monochromator-based photometer was used for acquisition
of the spectral data. When, instead of a monochromator-based, a diode array-based photometer
is applied, the spectral data can be acquired on a real-time scale. In theory, this enables in-line
monitoring of preparative chromatography processes. Based on a model system, we investigated
the possibility to perform in-line monitoring of chromatographic separations based on absorption
spectra measured in the column eluate.
113
1 Introduction
Product purity is the most important objective in the manufacturing of protein therapeutics. Of
course, process parameters such as yield and throughput are also important, however without
purity there will be no product. State of the art protein purification processes are required to
be based on identified product quality attributes and their detailed and documented linkage
to process parameters. At the stage of manufacturing a detailed process control strategy must
be in place. The developed control strategy is aimed at ensuring very high as well as highly
reproducible quality based on different control elements and the knowledge of the links between
process parameters and product quality. A control strategy consists of numerous elements
including process control elements such as Procedural Controls and Process Parameter Controls
and testing control elements such as In-Process Testing, Specifications, and Process Monitoring.
In-process testing is defined as measurements performed during processing. If the analytical
procedure on which the test is based is performed in the process stream, the term in-line
analytics is used.
A common strategy to achieve high purity is the use of orthogonal purification steps, each of
which is designed to robustly remove specific impurities. The robustness of a purification step
is often achieved by using well defined pooling criteria such as complete ‘load flow through’ or
complete ‘eluate’ collection. The draw back of such a process design is the limited application
of high resolution steps as these would require more sophisticated pooling criteria.
An established purification process must capable to cope with variabilities in the material
to be processed. However, this can lead to very conservative process parameters settings, in
order to ensure quality. By having real time in-process testing in place, the process can react
to variability such as e.g changes in column performance, buffer variability, or the amount of
impurities. Recently, Kaltenbrunner et al. [6] suggested the application of a chromatographic
process analyzer and based the pooling criteria on the data generated by the process analyzer.
A schematic of the set up is displayed in Fig.1.
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Figure 1: Fast on-line HPLC analytic for in-process control. The chromatogram shows a purification
step after a refolding process where misfolded protein is separated from the target protein. The figure is
adapted form the original work by Kaltenbrunner et al. [6].
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Figure 2: Proposed process control scheme based on analysis of spectral data. If the spectral of the
target product and the impurity are different, process control can be based on the spectral data recorded
during separation.
We have recently developed strategies to perform very fast HPLC based protein analytics [2,
4]. These methodologies have potential to be used to establish very fast analytics as needed when
performing fast on-line HPLC analytic for process control. However, it is still very challenging
to get a precise chromatographic analysis fast enough for real time in-process control. As
a consequence, some kind of delay compensation must be build in the control system. We
have recently shown that protein mid-UV absorption spectra contain information which can be
robustly correlated to selective protein concentration in a protein mixture [5, 3]. The used of
a diode array detector (DAD) makes it possible to perform complete wave length scans with a
high frequency during a preparative chromatography step. We hence propose the that in cases
where the spectra of the target protein and the impurity which is to be removes are different,
the spectral data can be used as in-line process analytic, by generating selective protein signals
during processing. In Fig.2 a schematic of the control system based on spectral data is displayed.
2 Methods and Materials
2.1 Chromatography System
An UltiMate3000 RSLC system from Dionex (Sunnyvale, CA, USA) was used. The system
was composed of one HPG-3400RS pump, a WPS-3000TFC-analytical auto sampler and a
DAD3000RS detector. The auto sampler was equipped with a 100µL sample loop. The volume
of the injection needle was 15µL and the syringe size was 1000µL. For control of the HPLC
equipment and for data evaluation the Chromeleon software (6.80 SR10) was used.
2.2 Selective Protein Concentration Calibration
100 µL of each calibration sample, in this case pure protein, was injected directly into the diode
array detector via the auto sampler. The calibration was based on spectra from each pure
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protein, one spectrum created from a linear combination of both pure spectra, and one buffer
spectrum. The calibration was based on PLS regression with two latent variables and mean
centering was used as preprocessing.
2.3 Proteins
All proteins were purchased in solid form from Sigma-Aldrich (St. Louis, MO, USA). The
applied proteins were: hen egg white lysozyme (HEWL), human breast milk lysozyme (HBML)
expressed in rice, bovine α-lactalbumin (α-lac), and bovine ribonucleaseA (ribA).
2.4 SEC Runs
The SEC runs were performed using a 0.2 M potassium phosphate buffer at pH 6.2 containing
0.25 M potassium chloride. Buffers were filtered through 0.2 µm filters (Sartorius, Germany)
prior to use. All protein solutions were prepared in this buffer. The chromatography runs were
performed with a 15 cm ZENIX SEC-250 column (Sepax Technologies, Newark, DE, USA).
The column was fitted with a 0.2 µm inlet filter (Opti-Solv, Optimize Technologis, Oregon City,
OR, USA). The flow rate was 0.4 mL/min. The data collection settings were as follows: data
collection rate = 1 Hz, bunch width = 1 nm, slit width = narrow.
3 Results and Discussion
As the setup of the used system did not yet allow for real time access to the spectral data, the
data processing was performed after completion of each chromatographic run. The data was
automatically saved in a folder. The numerical computing environment MATLAB was used to
process the data. First, the calibration data were loaded and the regression model was build.
The model was based on each of the pure spectra, one computed mixture spectrum, and one
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Figure 3: Selective protein signals generated on the basis of the mid-UV protein spectra. The concept
was shown for two binary protein mixtures of which the spectra were similar to a different degree.
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buffer spectrum. After the model was calibrated, the data form the chromatographic run was
loaded and the selective protein concentration for each point in time where a spectrum was
measured was calculated. This process only lasts a few seconds which makes it superior to
any process analyzer based on HPLC analytics. In Fig. 3, the result of two chromatographic
runs are shown. Left is the separation of ribA and α-lac which have rather different spectra.
Right is the separation of HEWL and HBML which have very similar spectra. Even for the two
proteins with very similar spectra, the quality of spectral data was high enough to give stable
protein signals. The mass balances were in the range from 80 – 110 %. This will of cours not be
acceptable if the procedure is to be used as an in-line process control tool. The reasons for the
deviating mass balances is thought to be due to the pipetting of the calibration samples and
protein mixtures. Further, the used model proteins does come with some impurities. If these
impurities are separated form the main component during the SEC run, the calibrated model
will calculate falsely concentrations.
4 Conclusion and Outlook
The presented work show that selective protein signals can be generated based spectra data
recorded with a DAD. This is advantageous as it opens up for the possibility to used this for
in.line process control. As it was not possible to access the spectral data in real time with
the present setup of the chromatography system, this work was limited to a proof of principle
based on the off-line data after a chromatographic run was performed. This work serves as
the starting point for a PhD project which is planned establish the necessary requisites for real
time data evaluation. Further, it will be attempted to combine the generated selective protein
signals with mechanistic modeling aiming at a very high level of process control.
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4 Conclusion & Outlook
Original methodologies to increase throughput in protein analysis were developed. In this thesis,
a more efficient use of chromatography systems was shown to result in a three fold decrease
in analysis time for aggregate quantification based on SEC analysis. The decrease in analysis
time came from the elimination of the lag time otherwise inherent in SEC analysis. Hence, the
actual information produced by the analysis was not altered. The methodology can be realized
for any chromatographic analysis which is performed exclusively in isocratic mode. Further,
multivariate calibration was proven capable of generating precise quantification despite low
chromatographic resolution. In this context was shown that a dynamic calibration approach
was able to cope with changes in analytical column performance over time which poses a problem
when using a static multivariate calibration. Each of these methodologies can be used alone or
in combination depending on the analytical task. In order to make these approaches readily
available in settings with limited time for establishment of analytical methods or where the
expertise is not at hand, it would be highly advantageous to make the presented methodologies
available in the commercial chromatography software.
Original work on the use of spectral based selective protein quantification proved that mid-
UV protein absorption spectra are very useful for this purpose. The analytical methods which
were developed based on the mid-UV absorption spectra can be performed in micro titer plates
which enables a very high throughput for selective protein quantification. The spectra of a
great range of proteins were investigated, and it was shown that the approach is applicable even
for proteins with very similar spectra. One of the limitations was shown to be inaccuracies
related to the geometry of the liquid surface of the protein samples in the wells of a micro titer
plate. Hence, future work is aimed at developing chip based UV measurement devise, where the
protein samples can be measured with a defined path length. The challenge will be to maintain
throughput and sensitivity of the current plated based spectrophotometers.
The potential of the use of mid-UV absorption spectra for in-line process control of prepar-
ative chromatography was shown. However, difficulties in accessing the data in real time were
experienced. Future work will aim intensively at the establishment of an in-line process control
method based on spectral data. It would be very interesting to combine generated selective
protein signals with a mechanistic chromatography model. Such a combination might enable a
accurate prediction of process yield and remaining process time. This information can be used
to intensify process control and process monitoring. Further, the information could support the
preparation of subsequent process steps and hence increase overall process efficiency.
The use of mid-UV spectral data is currently finding use in several new research projects.
One application which has already been published is a method for determination of accurate
retention time of co-eluting proteins without prior knowledge on their spectra. This method can
for example enable parameter determination from protein mixtures for mechanistic modeling
of chromatography. Further, the method can be used to replace electrophoresis as the second
dimension in feedstock characterization.
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